Characterization of the signal sequence binding domain of Ffh by genetics and comparative analysis by Duncan, Stacy Stamey
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2010
Characterization of the signal sequence binding
domain of Ffh by genetics and comparative analysis
Stacy Stamey Duncan
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Bioinformatics Commons, and the Veterinary Preventive Medicine, Epidemiology,
and Public Health Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Duncan, Stacy Stamey, "Characterization of the signal sequence binding domain of Ffh by genetics and comparative analysis" (2010).
Graduate Theses and Dissertations. 11500.
https://lib.dr.iastate.edu/etd/11500
Characterization of the signal sequence binding domain of Ffh by genetics 
and comparative analysis  
 
by 
 
Stacy S. Duncan 
 
A dissertation submitted to the graduate faculty 
in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
 
 
Major:  Bioinformatics and Computational Biology 
 
Program of Study Committee: 
Gregory Phillips, Co-Major Professor 
Leslie Miller, Co-Major Professor 
Diane Bassham 
Drena Dobbs 
Cathy Miller 
 
 
 
Iowa State University 
Ames, Iowa 
2010 
Copyright © Stacy Duncan, 2010.  All rights reserved.  
ii 
 
TABLE OF CONTENTS 
 
LIST OF FIGURES         iv 
LIST OF TABLES         v 
ABSTRACT          vi 
CHAPTER 1. General Introduction                      1 
Dissertation Organization        1 
Introduction          1 
Literature review         1 
References          23 
   
CHAPTER 2. Essential features of the finger loop domain of Ffh as revealed by 
 random sequences          28 
 Abstract         28 
 Introduction         30 
 Materials and Methods       32 
 Results         37 
 Discussion         43 
 References         61 
          
CHAPTER 3. Methionine Bristles in the Signal Sequence Binding Domain of  
Ffh are not Required for Function of the Escherichia coli Signal Recognition 
 Particle                      65 
Abstract         65 
Introduction         67 
Materials and Methods       69 
Results         74 
Discussion         79 
References         93 
          
CHAPTER 4. Introduction to DraGnET      97 
Literature Review        97 
References         99 
 
CHAPTER 5. DraGnET: Software for storing, managing and analyzing  
annotated draft genome sequence data                             101 
Abstract         101 
Background         103 
Implementation        107 
Results         109 
Discussion         114 
iii 
 
Conclusions         116 
Availability and Requirements      117 
References         127 
 
CHAPTER 6. General Conclusions       130 
References         133 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
LIST OF FIGURES 
CHAPTER 1                      
Figure 1.  Structure of the M-domain of Ffh      22 
 
   
CHAPTER 2            
 Figure 1. Genetic system for screening a random sequence library for complementing 
  clones.          49 
 Figure 2. Phenotypes of ffh finger loop mutants.    50 
 Figure 3. Phenotypic classification of finger loop mutants.   51 
 Figure 4. Hydrophobicity plot of finger loop domain.   52 
 Figure 5. Hydrophobicity plot of finger loop domain.   53 
 Figure 6. Expression of finger loop mutants in vivo.    54 
 
          
CHAPTER 3 
 Figure 1. Structures of the Ffh M-domain.     84 
 Figure 2. Representatives of amino acids found in the M-domain of Ffh. 85 
 Figure 3. Comparison of Ffh M-domain sequences from bacteria and archaea 
 representing varying optimal growth temperatures.    86 
 Figure 4. Growth of ffhαM4 mutants.      87 
 Figure 5. Detection of products of mutant ffh alleles.   88 
Figure 6. Phenotypes of ffh M-domain mutants.    89 
Figure 7. SRP activity of ffh mutants.     90 
            
    
CHAPTER 5                                  
 Figure 1. Java classes.       118 
 Figure 2. DraGnET software architecture.     119 
 Figure 3. Web interface- DraGnET Home Page.    121 
 Figure 4. Adding a new strain.      122 
 Figure 5. Data Modification.       122 
 Figure 6. Updating gene information.     123 
 Figure 7. Quick Search.       124 
 Figure 8. Advanced Search.       124 
 Figure 9. BLAST Search.       125 
 Figure 10. Batch BLAST Search.      126 
 
 
 
 
v 
 
LIST OF TABLES 
 
  
CHAPTER 2            
 Table 1. Strains and plasmids used in this study    55 
 Table 2. PCR primers and oligonucleotides     57 
 Table 3. Summary of finger loop mutant sequences and growth data 58 
  
 
          
CHAPTER 3 
 Table 1. Strains and plasmids used in this study     91 
 Table 2. Ffh α4M domain mutants      93 
 
 
 
 
 
 
 
 
         
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
ABSTRACT 
 
 The signal recognition particle (SRP) is a ribonucleoprotein complex whose 
components are highly conserved throughout all three domains of life, where it functions to 
target proteins to extracytoplasmic locations.  In Escherichia coli, the SRP is comprised of a 
single essential protein (Ffh) in complex with a 4.5S RNA species.  To better understand how 
the structure of Ffh contributes to its function, we have used genetic approaches to isolate 
and characterize new ffh mutants altered in two distinct domains of the protein.  Both 
domains of interest have been implicated as being important for binding to hydrophobic 
signal peptides of membrane proteins.  These studies include using a random sequence 
approach to identify amino acids important for activity of the finger loop domain.  The finger 
loop was identified from structural analysis as a ~20 amino acid domain with the unusual 
properties of being both hydrophobic and exposed near the surface of Ffh.  Approximately 
1% of the random sequences were able to replace the FL domain of Ffh.   Bioinformatic 
analysis of the random sequences revealed that all of the complementing sequences followed 
a trend of high hydrophobicity at the amino-terminus that decreased towards the carboxy end.  
These observations were validated by observing that mutants that deviated from this trend 
rendered Ffh nonfunctional.  Mutants were characterized by growth rates that allowed the 
sequences to be grouped into three functional classes.  Secondary and tertiary structure 
predictions suggested that the products of the random sequences lack extensive secondary 
structure, which is consistent with the role of the finger loop in binding a variety of ligands.   
To address the importance of the conserved methionine residues at the carboxy-terminal 
region (M-domain) in SRP function, we combined phylogenetic comparisons with functional 
vii 
 
studies, including replacing methionine residues within the M-domain with other residues 
that varied in hydrophobicity, side chain flexibility and charge.  These studies revealed that, 
in E. coli, the M-domain of Ffh was able to tolerate substitutions of five different 
hydrophobic amino acids including valine, phenylalanine, tyrosine, tryptophan and isoleucine 
for the conserved methionine residues found in helix αM4 and the extreme C-terminus.  
Phylogenetic comparisons of microorganisms with varying optimal growth temperatures 
revealed methionine residues were substituted with amino acids containing less flexible side 
chains.  Interestingly, we observed that mutants containing less flexible residues were able to 
support cell viability at higher growth temperatures better than at lower temperatures.  
Phylogenetic comparisons also revealed three positions where methionine is highly 
conserved.  We show that replacing all of the methionine residues, except these three highly 
conserved residues, with valine yielded a functional SRP.  In contrast to predicted results, 
these studies reveal that the M-domain of Ffh is highly flexible in content and that 
methionines are not absolutely required for SRP function.  Collectively, these efforts have 
contributed to our understanding of SRP function by identifying key features essential for the 
function of the signal sequence binding domain of the Ffh protein component of SRP. 
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CHAPTER l. General Introduction 
 
Dissertation Organization 
 This dissertation is organized into six chapters including:  the first chapter containing the 
literature review; chapters 2 and 3 which contain papers in preparation; chapter 4 containing a 
brief review and introduction to chapter 5 which contains a published paper, all of which cover 
my doctoral research; and chapter 6 which includes a general conclusion of the work and future 
directions. 
 
Introduction  
 The following sections of this chapter will provide the reader with a review of literature, 
including scientific results, pertinent to the research detailed in subsequent chapters of the text.   
The literature review will begin with the initial discovery, using electron microscope technology, 
and biochemical characterization of the signal recognition particle (SRP) protein translocation 
pathway in eukaryotic cells.  Research leading to the discovery and characterization of the 
bacterial SRP, including the protein component termed Ffh (fifty-four homolog), will then be 
discussed.  Subsequent sections will focus on work elucidating the role of Ffh in SRP dependent 
protein localization in Escherichia coli, leading to our characterization of features of the Ffh 
protein important for its function.   
 
Discovery of a protein translocation mechanism                               
 Prior to the development and advancement of electron microscopy (EM) technology, 
details of the cellular biology of eukaryotic cells as well as bacteria remained largely unknown.  
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For example, eukaryotic cytoplasmic components such as ribosomes, organelles and the 
endoplasmic reticulum (ER) are too small to be clearly observed with conventional microscopy, 
but were resolved by the EM (31, 43).  Also, subcellular compartments of bacterial cells, 
including the outer and inner membranes, remained obscure until the advent of EM. 
 In the early to mid-1950’s George Palade used the EM to pioneer studies of protein 
localization.  He observed in eukaryotic cells that ribosomes, typically observed in the 
cytoplasm, were also found attached to the membrane of the ER (43).   A decade later, it was 
further observed that ribosomal attachment to the ER membrane was coupled with the co-
translational transfer of nascent peptide chains of secretory proteins across the membrane upon 
exiting the ribosome (43, 50).  Experimental data also revealed that synthesis of proteins retained 
in the cytosol occurs on free ribosomes while ribosomes synthesizing secretory proteins are 
recruited to the ER membrane (52).  Furthermore, it was observed that nascent chains of 
membrane bound ribosomes were resistant to proteolysis.  Specifically, the amino terminus 
segment of secretory proteins was resistant to digestion due to protection provided by the ER 
membrane.  This represented the first suggestion that the amino terminus might play an 
important role in ribosome membrane interaction (56, 57).  Blobel and Sabatini used these 
observations to attempt to explain why ribosomes actively translating secretory proteins are 
recruited to the ER membrane while ribosomes translating cytosolic proteins are not.  They 
postulated that mRNAs destined to be translated on membrane-bound ribosomes contain a 
unique DNA sequence located at the 5' end which, upon emerging from the ribosome, would 
“signal” attachment of the ribosome to the membrane.  Subsequent translocation of the protein 
across the ER membrane would occur co-translationally, i.e., concomitant with polypeptide 
elongation (57).  Experimental support for their hypothesis was provided in the early 1970’s.  
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Several research groups observed that a model secretory protein, IgG light chain from murine 
myelomas translated in vitro on free ribosomes had a higher molecular weight than the actual 
secreted light chain.  In vitro synthesis of the IgG light chain on membrane-bound ribosomes, 
however, yielded a product with the same molecular weight as the secreted light chain product 
(38, 41, 58, 59, 67, 71).  It was also shown that the amino terminus of the in vitro translation 
product of the light chain contained an additional ~20 amino acids not found in the secreted light 
chain (58).  This discovery led to the proposal that the ~20 amino acid extension initiates binding 
of the ribosome to the ER membrane (41).   
 Subsequently, in 1975, to elucidate the previous findings, Blobel and Dobberstein 
confirmed the previously mentioned results and further demonstrated that the lower molecular 
weight of the secreted light chain resulted from cleavage of the additional sequence found at the 
amino terminus.  Importantly, the processing of the amino terminus occurred only in proteins 
destined for secretion. They also demonstrated that processing of the additional sequence, termed 
the “signal sequence,” occurred before completion of the nascent peptide and was coupled to 
protein translocation into or across the ER membrane (7).  Subsequently, using a heterologous in 
vitro system comprised of translation factors from plants, ER from dogs and ribosomes from 
rabbits, it was shown that translocation of the protein still occurred; indicating the mRNA and 
not the ribosome contains the information necessary for the localization of nascent chains of 
secretory proteins to the ER membrane (8).  In the mid 1970’s Blobel and Jackson were able to 
show that post-translational cleavage of signal peptides of pre-secretory proteins occurred via 
activity of a signal peptidase (24).  Ultimately, the results presented by Blobel and Dobberstein 
led to a more detailed version of the hypothesis that was previously proposed by Blobel and 
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Sabatini in 1971 and was referred to as the “signal hypothesis”.  This discovery ultimately 
resulted in Blobel being awarded the Nobel Prize in Physiology or Medicine in 1999.   
 
Discovery and characterization of the SRP 
 Although the signal hypothesis was well established, very little was known about the 
factors involved in the co-translational transfer of nascent chains across the microsomal 
membrane.  In an attempt to characterize these factors, Warren and Dobberstein (81) 
disassembled microsomal membranes into components involved in protein translocation by 
treating rough microsomes with high salt.  Their results revealed that high salt treatment of 
membranes greatly reduced the protein translocation activity of the membrane, while addition of 
the salt extracts restored activity.  They also observed that components of the salt extract were 
unable to re-establish protein translocation to microsomes that were treated with the protease 
trypsin.  They proposed that proteins, not RNA, were the active components of the salt extract 
since the microsomes were treated with RNase prior to extraction.  Based upon their results, they 
concluded that the extracted membrane proteins participate in signal sequence binding and 
binding of the ribosome nascent chain complex to the membrane and that other membrane 
proteins are involved in subsequent transfer of proteins across the membrane.          
 Using a similar approach to characterize the translocation activity of microsomes, Walter 
et al. used different concentrations of trypsin to fractionate microsomal membrane translocation 
activity into two components, a cytosol exposed soluble domain and a membrane-bound domain 
(79).  They found that trypsin treatment abolished translocation activity of the membrane 
component; however, the activity could be restored upon addition of the soluble component.  
This led to their proposal that the cytosol-exposed soluble portion contains the signal sequence 
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and/or ribosome recognition domain and the membrane-bound component spans the membrane, 
which allows for protein transfer.  Their conclusion conflicted with results previously reported 
that a peripheral not a membrane spanning protein component was involved in protein 
translocation (81). 
 In an attempt to resolve previous conflicting results, Jackson et al. (25) studied the 
components of the salt extract reported by Warren and Dobberstein and the trypsin extract 
reported by Walter et al. (79).  The extracts were treated with N-ethylmaleimide, a sulphydryl 
modifying reagent shown to inhibit translation (29), and subsequently were unable to restore 
translocation activity to microsomal membranes.  They further showed that untreated extracts 
were able to restore translocation activity to membranes that were inactivated by N-
ethylmaleimide treatment.  These observations led to the conclusion that both extracts contain 
components that are similar both structurally and functionally and contain sulphydryl on the 
cytoplasmic domain important for protein translocation. 
 Walter and Blobel (74) continued to characterize factors required for protein 
translocation.  Using hydrophobic chromatography, they were able to purify the component of 
the salt extract previously found to restore translocation activity to inactive membranes (81).  
Using polyacrylamide gel electrophoresis, they observed that the component was comprised of 
six proteins thought to be found in complex with one another since they were found in 
stoichiometric amounts.  They further observed that the complex was the only component of the 
salt extract found to bind the hydrophobic matrix of ω-aminopentyl-agarose, which led the 
authors to propose that the exposed hydrophobic region of the protein complex participates in 
hydrophobic signal sequence recognition (74). 
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 In a series of three papers Walter and Blobel detailed their attempts to explicate the 
mechanism by which the previously purified protein complex, termed the signal recognition 
protein (SRP), mediates translocation of secretory proteins across the ER membrane.  In the first 
paper, they observed that the translation of proteins was inhibited when salt extracted membranes 
were absent (78).  To elucidate the specificity of what they observed, they added SRP complex to 
a translation system that lacked membrane vesicles but contained mRNAs encoding cytoplasmic 
proteins, α and β globin, and the secretory protein preprolactin.  They observed that the SRP 
inhibited translation of the secretory protein but not the cytoplasmic proteins.  They proposed 
that inhibition was due to direct interaction of the SRP complex with ribosomes translating 
secretory proteins.  Subsequently, using radioactively labeled SRP, direct binding of the complex 
with ribosomes translating secretory proteins, but not cytoplasmic proteins was established.  To 
better understand the nature of the SRP/protein interactions, they used a leucine analog, β-
hydroxyl leucine, previously shown to abolish in vitro translocation of preprolactin when 
incorporated into the nascent chain (22).  They found that the SRP neither bound ribosomes 
translating preprolactin nor inhibited translation of preprolactin containing β-hydroxyl leucine.  
However, once β-hydroxyl leucine was competed out with leucine, binding of the protein 
complex with ribosomes translating preprolactin was re-established and translation was 
inhibited. Additionally, it was previously shown that protein translocation was impaired when 
microsomal membranes were treated with N-ethymaleimide and subsequently, the impairment of 
the translocation mechanism was localized to SRP (74).  By treating SRP with N-ethymaleimide, 
they found that the SRP no longer interacted with preprolactin translating ribosomes.  
Altogether, their results showed that the SRP binds ribosomes translating secretory proteins and 
suggested the signal sequence of the nascent chain mediates the binding event.      
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 In the second paper, the role of SRP in the binding of ribosomes translating secretory 
proteins to microsomal membranes was investigated (77).  To examine binding of ribosomes to 
membranes, the researchers designed an assay using an in vitro translation system and 
differential centrifugation.  They indirectly measured the binding of ribosomes to the membrane 
by measuring the amount of mRNA in the translation system that remained once mRNA 
contained in membrane bound ribosomes translating secretory proteins were removed using 
differential centrifugation.  They showed that membranes, whose translocation activity had been 
depleted due to salt extraction, were unable to bind to ribosomes translating preprolactin in the 
absence of SRP.  This led to the conclusion that SRP is essential for binding of the ribosome-
nascent chain complex to microsomal membranes.  Furthermore, they found when β-hydroxyl 
leucine was incorporated into the nascent chain of a secretory protein, the ribosome-nascent 
chain complex no longer bound to microsomes; however this could be overcome by competing 
out β-hydroxyl leucine with leucine, thus validating that the nascent chain contains information 
(the signal sequence) required for ribosome-nascent chain complex binding to membranes.      
 In the third and final paper in this noteworthy series, Walter and Blobel (76) investigated 
their observation that SRP selectively inhibited synthesis of secretory proteins but not of 
cytoplasmic proteins.  To examine this phenomenon, the researchers used a synchronized 
translation system that included a compound known to block initiation of protein synthesis and a 
radiolabeled methionine residue ([
35
S] Met), allowing them to follow each step of the of protein 
synthesis process.  They monitored the incorporation of [
35
S] Met into preprolactin and observed 
a decreased rate of incorporation in the presence of SRP but without microsomal membranes, 
indicating arrest in translation.  Subsequently, when they added salt extracted membranes, amino 
acid incorporation increased significantly, indicating a release in elongation arrest imposed by 
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the SRP.  Additionally, they found that translation resumed once ribosomes bound to microsomal 
membranes.  Further, protein synthesis was completed while the protein was simultaneously 
translocated into or across the membrane.  Collectively, these results led to the characterization 
of the SRP-dependent protein localization pathway for secretory proteins that involves the 
following steps:  first, emergence of the signal sequence from the ribosome triggers binding of 
the SRP to the ribosome-nascent chain complex causing an arrest in translation; second, the 
SRP-ribosome-nascent chain complex binds to the membrane releasing elongation arrest that 
allows for co-translational translocation of the protein across the membrane. 
Continued characterization of the SRP led to the discovery of two additional components 
essential for the translocation of secretory proteins.  Initially, it was thought that the SRP was 
comprised of only proteins since microsomes remained active even after RNase treatment (81).  
However, Walter and Blobel (75) discovered that a 7S RNA was indeed an essential component 
of the SRP complex.  This led to renaming the signal recognition protein to the signal 
recognition particle.  Gilmore et al. (19, 20) and Meyer et al. (40) discovered another component 
of the translocation pathway termed the docking protein or the SRP receptor.  Both groups 
reported the discovery of a 72K protein (SRP receptor) located in the ER membrane required for 
binding of the SRP-ribosome-nascent chain complex to the membrane and the subsequent release 
of translation arrest and translocation of secretory proteins across the membrane.   
 
Search for an SRP pathway in bacteria 
 Although the mechanism of protein translocation mediated by the SRP had been well 
established in eukaryotes, a similar mechanism was only later found in bacteria.  Despite 
extensive genetic and biochemical analysis of bacterial protein export, no evidence of an SRP 
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resulted (7, 14, 64, 65).  In contrast to eukaryotic systems, the use of genetic approaches 
pioneered the discovery of components of the protein export machinery in bacteria.  Prior to 
these efforts, it was unclear how proteins were targeted to the outer membrane, periplasmic space 
and inner membrane.  In an early study Emr et al. (17) constructed a gene fusion by joining the 
coding regions for the integral outer membrane protein LamB, the receptor for the bacteriophage 
λ, with the cytoplasmic enzyme β-galactosidase, encoded by lacZ.  Since LamB was known to 
contain a signal sequence at the amino terminus and shown to be synthesized by membrane 
bound ribosomes (49), the authors reasoned that β-galactosidase would likewise be targeted 
outside of the cytoplasm.  Indeed, when a sufficient portion of LamB was included in the hybrid 
protein, β-galactosidase was exported outside of the cytoplasm.  Importantly, β-galactosidase no 
longer was functional outside of the cytoplasm, hence providing genetic selections and screens 
for isolation of E. coli mutants defective in export of the LamB-LacZ hybrid protein.  
Subsequent studies were instrumental in defining important features of the signal sequence for 
efficient export, including maintaining a sufficient level of hydrophobicity and the ability to form 
a α-helix (12, 39).    
Further comparison of prokaryotic and eukaryotic signal sequences revealed both were 
similar in composition, a short hydrophilic basic region followed by a hydrophobic stretch of 
amino acids.  Talmadge et al. (68) were able to show that when a eukaryotic signal sequence was 
fused to a periplasmic protein in E. coli, efficient targeting to the periplasmic space was 
observed, suggesting a common mechanism for protein localization.  
Additional genetic approaches led to the discovery of several components of the Sec 
(secretion) protein export apparatus, including SecA, SecB, SecY, and SecE.  However, despite 
attempts to the contrary, none of these proteins proved to be equivalent to the SRP (82).   
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 Although forward genetic approaches failed to reveal the bacterial SRP, continued 
analysis of eukaryotic SRP components eventually lead to the discovery of homologous bacterial 
components shown to be involved in protein localization in E. coli.   
 
Evidence of SRP in bacteria 
 Evidence for the bacterial SRP was first presented by homology comparisons.  Using 
sequence similarity and structure prediction analysis it was discovered that a highly conserved 
region of eukaryotic 7S RNA, helix 8, was homologous to 4.5S RNA in E. coli (47, 66), 
suggesting that 4.5S RNA was a component of the protein translocation mechanism in E. coli.  
However, 4.5S RNA had previously been shown likely to be involved in protein synthesis, with 
no evidence for a role in protein localization (10).  Subsequently, two different groups (5, 53) 
cloned the structural gene for SRP54 and found significant homology between this protein and 
two predicted gene products from E. coli.  These included a 48K protein with unknown function 
designated P48 or Ffh (fifty-four homologue) and FtsY, a protein though to be involved in cell 
division (18).  This latter protein was also strikingly similar to the α-subunit of the eukaryotic 
SRP docking protein (DPα or SRα).  While SRP54 and Ffh shared three homologous domains, 
including a N-terminal domain of unknown function, a GTP-binding domain (G domain) and a 
methionine rich carboxy-terminal domain (M-domain), similarity to FtsY/ SRα was limited to 
the G domain. 
While these findings were intriguing, sequence homology did not provide the 
experimental evidence needed to prove that an SRP protein translocation mechanism existed in 
bacteria.  Furthermore, because genetic screens for export mutants never identified these 
components, the hypothesis was met with great cynicism (1, 3, 10).      
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 Continued analysis of E. coli, however, eventually led to the confirmation that Ffh and 
4.5S RNA comprise the SRP complex in bacteria.  First, studies conducted independently by 
Ribes et al. (51) and Poritz et al. (46), examined whether Ffh can form a SRP-like complex in E. 
coli.  Initially, they found that eukaryotic SRP 7S RNA could functionally replace 4.5S RNA in 
E. coli and that over expression of SRP54 and Ffh as well as depletion of 4.5S RNA were 
detrimental to cell growth, as had been observed earlier by Brown (10).  Additionally, 
immunoprecipitation experiments demonstrated that both Ffh and SRP54 were able to bind 4.5S 
RNA in vivo.   Furthermore, they found that the Ffh-4.5S RNA complex could be functionally 
replaced by SRP54-4.5S RNA in vitro.  Altogether, their results demonstrated that Ffh and 4.5S 
RNA forms a ribonucleoprotein complex in E. coli and suggested it may be functionally similar 
to the eukaryotic SRP.    
 Given that SRP54 was shown to bind 4.5S RNA, Bernstein et al. (6) hypothesized that 
Ffh could bind eukaryotic SRP 7S RNA and form a chimeric SRP that would be functionally 
comparable to native eukaryotic SRP.   Initially, to test if Ffh could bind to SRP 7S RNA, they 
mixed Ffh with SRP 7S RNA and five other SRP protein subunits.  Using sucrose gradient 
sedimentation to analyze the resulting products, they found that Ffh was able to bind SRP 7S 
RNA as efficiently as SRP54 used in a control reaction.   Additionally, using a crosslinking 
assay, they showed that Ffh, in place of SRP54, was able to recognize signal sequences of 
secretory proteins.  These results provided additional evidence that Ffh and 4.5S RNA form a 
ribonucleoprotein complex in E. coli with similar function to that of eukaryotic SRP.   
 In 1992, studies performed by Luirink et al. (34) provided conclusive experimental 
evidence that Ffh-4.5S RNA form a functional SRP in E. coli.  Using a photo crosslinking assay 
previously used to demonstrate that SRP54 binds the signal sequence of the nascent secretory 
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protein preprolactin (32, 33), they found that Ffh crosslinked to signal sequences of nascent 
secretory proteins in crude E. coli extracts.   They also performed the crosslinking assay with 
free Ffh in the absence of 4.5S RNA and found that crosslinking of signal sequences with Ffh 
was greatly reduced.  This indicated that 4.5S RNA is required for the recognition of signal 
sequences by Ffh.  Experimental support that SRP54 and Ffh were functionally similar was 
further provided when the authors found that SRP54 competed with Ffh for binding the signal 
sequence of the preprolactin secretory protein.   
 Evidence that Ffh is an essential gene product in E. coli was first provided by Phillips and 
Silhavy (45).  They constructed a strain of E. coli where the sole copy of ffh was placed under 
control of the araB operator and promoter and showed E. coli growth was dependent on the 
presence of arabinose.  Upon depletion of Ffh by removal of arabinose they observed multiple 
phenotypes, including defects in cell division and a defect in signal sequence processing of 
several exported proteins.  Their results suggested that the bacterial SRP plays a role in protein 
localization; however, the exact mechanism of SRP dependent protein localization required 
further investigation.  It was also shown that genes encoding the other putative components of 
the SRP pathway, i.e., ffs and ftsY, are also essential for cell viability in E. coli (11, 35). 
 
Role of E. coli SRP  
 One of the first studies to suggest that the SRP function in localization of a subset of E. 
coli proteins was provided by MacFarlane and Müller (37).   They observed that the uptake of 
the lactose analog 2-nitrophenyl-β-D-galactopyronaside (NpGal) was dependent upon the proper 
localization and insertion of the lactose permease (LacY), a transmembrane protein, into the 
inner membrane.  By determining the rate of NpGal uptake they were able to monitor the amount 
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of LacY that was being localized to the inner membrane.  The uptake of NpGal was measured 
under two different conditions, each involving a disruption of the SRP complex.  First, using a 
dominant lethal 4.5S RNA mutant (46) to disrupt the SRP, they observed a decrease in LacY 
activity.  Second, by depleting cells of Ffh (45), they again observed a decrease in the levels of 
LacY.  Using Western Blot analysis they showed that the decreases were not due to a reduction 
in LacY synthesis or increased protein instability.  These results indicated the membrane 
insertion of LacY had been impaired due the inactivation of the SRP.  In contrast, upon 
inactivating SecA function they did not observe a defect in LacY activity.  Their results 
suggested that the E. coli SRP functions in targeting proteins to the inner membrane, while the 
Sec pathway is specific for targeting periplasmic and outer membrane proteins.     
 A more direct test of the role of SRP in membrane protein localization was soon made by 
de Gier et al. (15).  Using the cytoplasmic membrane protein leader peptidase (Lep) as a model, 
they showed that localization of this protein was severely disrupted upon depletion of either 4.5S 
RNA or Ffh.  In contrast, localization of OmpA to the outer membrane was not affected.   
 Several groups continued to use depletion systems to elucidate the role of each factor of 
the SRP pathway in targeting various proteins.  Each group reported that depletion of Ffh or 4.5S 
or FtsY strongly affected the insertion of inner membrane proteins and only weakly affected 
targeting of secreted proteins (16, 60, 72, 73).    
 A novel genetic approach was used by Ulbrandt et al. (72) to elucidate the role of the E. 
coli SRP in protein targeting.  This group performed a genome-wide screen in an E. coli SRP 
mutant with the prediction that when the amount of SRP is limited in the cell, overproduction of 
proteins whose localization is SRP dependent would titrate out the remaining SRP, hence 
causing a reduction in cell viability.   To test this, Ulbrandt et al. expressed a plasmid library in 
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an E. coli strain where ffh was under control of the inducible trc (trp-lac) promoter and present in 
single copy.  In screening the plasmid library for transformants that grew only in the presence of 
isopropyl-β-D-thiogalactopyranoside (IPTG), the authors identified eight inner membrane 
proteins (IMPs) that required sufficient levels of SRP for viability.  The researchers referred to 
the resulting phenotype as “SLO” (synthetic lethality upon overexpression).  It was also noted 
that all eight IMPs exhibiting the SLO phenotype were predicted to span the cytoplasmic 
membrane multiple times.  Additionally, none of the proteins were predicted to contain cleavable 
amino-terminal signal sequences; rather their signal sequences were located in the internal 
membrane spanning domain, a feature common to most IMPs.  This was the first evidence to 
suggest that SRP uses hydrophobicity to select signal sequences for protein targeting and further 
supported the hypothesis that the SRP is specific for localization of IMPs.  Further 
characterization of these proteins showed that their localization to the cytoplasmic membrane 
required a functional SRP pathway.      
An independent genetic approach was used by Park et al. (44) to study the role of Ffh in 
membrane protein targeting.  By isolating a temperature-sensitive ffh mutant, they were able to 
overcome a limitation inherent to systems that used depletion of a gene product by repressing its 
synthesis.  Park et al. pointed out that these systems typically require an extended growth period 
that may result in secondary effects that can mask the true physiological function of the protein.  
In the case of Ffh this is an especially relevant concern as it was shown that even low levels of 
Ffh can support cell viability (4) and depletion of the gene product can take multiple generations 
of growth.  The temperature sensitive ffh (ffh
TS
) mutant isolated by Park et al. resulted in the 
rapid inactivation of the gene product when growth was shifted from the permissive temperature 
of 30
o
C to the nonpermissive temperature of 42
o
C.  Using this system, the authors clarified the 
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results from prior studies and showed that soon after a shift to the non-permissive growth 
temperature membrane protein localization was impeded, while signal sequence processing of 
periplasmic and outer membrane proteins remained efficient, consistent with a role of the SRP in 
membrane protein targeting. 
Despite the insights into SRP function provided by the studies just described, a question 
remained as to why SRP mutants had never been isolated by previous genetic efforts to study 
protein localization in E. coli.  To approach this, Tian and Beckwith revisited the use of lacZ 
gene fusions to screen for mutants with reduced efficiency of targeting a MalF-β-galactosidase 
hybrid protein to the inner membrane.  Initially, the researchers developed a genetic screen 
utilizing a strain that expressed a MalF-β-galactosidase hybrid protein.  They reasoned that 
mutations in genes necessary for targeting membrane proteins would prevent efficient insertion 
of the MalF-β-galactosidase protein.  As a consequence, accumulation of the β-galactosidase 
moiety in the cytoplasm would restore a Lac
+
 phenotype.  However, their selection for Lac+ 
mutants only yielded mutations in genes involved in disulfide bond formation (70).  By 
modifying their approach, they screened for cells that displayed only a modest increase in β-
galactosidase activity.  Using this approach they found mutations in genes that encode 
components of the E. coli SRP pathway, ffh, ffs and ftsY (69, 70).   While the screen for increased 
enzyme activity of the MalF-β-galactosidase was ultimately a successful strategy for isolating 
SRP mutants, the initial studies were limited by the requirement for relatively high levels of β-
galactosidase activity. 
In the characterizing these new ffh and ffs mutants, Tien and Beckwith used a facile 
technique for monitoring membrane protein localization.  Previously Jander et al. (27) reported 
that proteins tagged with the biotin-accepting domain from the 1.3S subunit of a 
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transcarboxylase from Propionibacterium shermanii (PBST), were biotinylated only when the 
fusion protein was localized in the cytoplasm.  By creating translational fusions of PBST to the 
carboxy-terminus of selected membrane proteins, the location of the polypeptide could be 
monitored by measuring the level of biotinylation.   For example, expression of the SRP-
dependent inner membrane proteins FtsQ-PSBT (possessing a single transmembrane spanning 
domain) and AcrB-PSBT (possessing multiple membrane spanning domains) showed evidence 
of biotinylation in ffh, ftsY and ffs mutants (69, 70). 
 Collectively, research indicated that unlike the eukaryotic SRP, the primary function of 
the E. coli SRP is to co-translationally target inner membrane proteins.  From this, it was further 
hypothesized that the mode of co-translational targeting as opposed to post-translational 
targeting is employed by the bacterial SRP in order to prevent hydrophobic segments of inner 
membrane proteins from aggregating or folding prematurely in the cytoplasm (48).   
         
Signal Sequence Recognition by the SRP           
 Understanding details of the mechanism by which SRP recognizes hydrophobic signal 
peptides was approached independently by Kurzchalia et al. and Krieg et al. (32, 33), who 
reported a direct interaction between the signal sequence of the secretory protein preprolactin 
and SRP54.  The researchers used an assay where they incorporated a photochemically reactive 
probe into two lycine residues found in the signal sequence of the nascent chain of the secretory 
protein preprolactin by using modified aminoacyl-tRNAs. They found that the photoreactive 
preprolactin signal sequence crosslinked to the 54K protein component of the SRP and also 
immunoprecipitated with antibodies specific for the prolactin and 54K proteins.   Their results 
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suggested that the 54K protein of the SRP recognizes and binds to the signal sequence of 
secretory proteins as they emerge from the ribosome.  
 Inspection of the SRP/Ffh sequence led Bernstein et al. (5) to propose a model for signal 
sequence binding that suggested that the signal sequence binding region is contained in the 
methionine rich M-domains of these two proteins.  Predictions of SRP54/Ffh secondary structure 
suggested the M-domain was comprised of three α-helices, two of which contain all of the 
conserved methionine residues of the helical region, along with other hydrophobic amino acids, 
clustered on one face with polar residues on the opposite face.  The researchers hypothesized that 
the hydrophobic nature and side chain flexibility of the methionine residues along with their 
spatial arrangement with other hydrophobic residues form a groove on the protein surface that 
contributes to the plasticity of the region which would be required for binding hydrophobic 
signal sequences that vary in length and amino acid composition.  Furthermore, they proposed 
that the side chains of the methionines protrude out into the groove forming what is now known 
as the “methionine bristle” which would allow signal sequences to bind through hydrophobic 
interactions.   
 Several independent studies revealed that the M-domain of SRP54 indeed contains the 
binding sites for signal sequences of secretory proteins as well as SRP 7S RNA (21, 36, 54, 84).  
This latter interaction was shown by using C-terminal truncated versions of SRP54, Romisch et 
al. (54) that showed that the methionine rich M-domain mediates binding of SRP54 with SRP7S 
RNA.  They further showed that the M-domain of SRP54 is able to bind E. coli 4.5S RNA.   In 
studies conducted by Zopf et al., (84) and High and Dobberstein (21), SRP was digested with V8 
protease, which was previously shown to cleave SRP54 into two distinct fragments, the amino-
terminal NG domain and the carboxy-terminal M-domain (54).  Using a photo crosslinking 
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assay, they found that the signal sequence of preprolactin consistently crosslinked to the M-
domain of SRP54.   To this point, the signal sequence recognition site of Ffh had been 
investigated using the cleavable signal sequence of preprolactin.  However, Lutcke et al. (36) 
wanted to determine if a membrane protein, IMC-CAT that contains an uncleaved signal anchor 
sequence also interacted with the M-domain of SRP54.  Additionally, they wanted to test if the 
M-domain alone was sufficient for binding signal sequences.  Using a similar photo crosslinking 
assay to that of Zopf et al. (84) and High and Dobberstein (21), they found that the uncleaved 
signal sequence of the membrane protein IMC-CAT was crosslinked to the M-domain of SRP54.  
Additionally, free SRP54 containing only the M-domain was found to be crosslinked to the 
signal sequence of both preprolactin and IMC-CAT indicating that the M-domain is sufficient for 
signal sequence recognition.   
 
Structure of Ffh M-domain 
 In the late 90’s, the crystal structure of full length Ffh from Thermus aquaticus was 
determined and provided further support for the predicted structure of the M-domain and the 
“methionine-bristle” hypothesis (30).  The crystal structure revealed the three domains of Ffh: 
the N domain, the G domain and the M-domain.  The M-domain was shown to contain four 
alpha helices, αM1, αM2, αM3 and αM4 that are arranged to form a hydrophobic groove 
exposed on the surface of the protein (30).  As shown in Figure 1A, the proposed hydrophobic 
signal sequence binding groove is formed by αM1 and αM2, connected by a flexible loop called 
the “finger loop”, and αM4.  Helix αM3 contains the binding domain for the SRP RNA (80).  
The crystal structure along with sequence analysis showed the majority of the surface of the 
binding groove is comprised of highly conserved methionines as well as other hydrophobic 
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amino acids; however, in thermophiles such as T. aquaticus many of the conserved methionine 
residues found in mesophilic organisms are replaced by other less flexible hydrophobic residues 
such as leucine, isoleucine and phenylalanine.  It was hypothesized that, because thermal motion 
is increased at higher temperatures, the need for the increased flexibility provided by the 
methionine side chain is eradicated (30).   
 Another component of the M-domain proposed to be involved in signal sequence binding 
is the highly conserved finger loop.  Evidence for this came from the crystal structures of the Ffh 
M-domains from T. aquaticus (30) and the human SRP54 M-domain (13), as well as the 
structure of the complete E. coli SRP (2).   In the crystal structure from T. aquaticus, Ffh was 
observed as a trimeric complex where two neighboring M-domains were connected such that the 
hydrophobic finger loop of one domain was inserted into the hydrophobic groove of the other 
domain.  Keenan et al. (30) hypothesized that the observed closed conformation of the finger 
loop in absence of a signal sequence served to protect the hydrophobic groove from solvents.  
The finger loop in the crystal structure of the E. coli Ffh M-domain-4.5S RNA complex was 
shown to be a disordered region of Ffh (2).  In the structure of the human SRP54 M-domain, the 
finger loop and α-helix 1 were shown to be inserted into the hydrophobic groove of a 
neighboring M-domain that was similarly hypothesized to protect the hydrophobic groove until it 
is displaced by a signal sequence (13).  Collectively, the three structures led to the proposal that 
the finger loop provides additional hydrophobicity and flexibility necessary for binding a variety 
of signal sequences and undergoes conformational changes in the presence and absence of a 
signal peptide.       
  
Continued analysis of Ffh and its interaction with other SRP components 
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 The function of the M-domain in Ffh was further probed biochemically by Zheng and 
Gierasch (83) who examined the effects of 4.5S RNA binding to this region of the protein.  
Using a V8 protease digestion assay, they found that binding of 4.5S RNA to Ffh protected the 
M-domain from complete digestion by the protease and was shown to stabilize this region of the 
Ffh protein.  Additionally, they found that 4.5S RNA binding to Ffh had no effect on signal 
sequence binding; however, when 4.5S RNA was absent, the M-domain was destabilized upon 
binding a signal sequence.  Interestingly, in vivo studies had previously shown that Ffh was 
stabilized by 4.5S RNA (28). 
 Subsequent biochemical and structural research has continued for the past decade to 
focus on structural determinations of the SRP and the SRP receptor, providing new insights into 
the interaction of these components.  Our current understanding is that SRP, bound to its cargo, 
forms a heterodimer with its receptor (FtsY in E. coli) that triggers GTPase activity of both 
proteins (61-63).   
 To begin to build a more comprehensive picture of how Ffh, 4.5S RNA and FtsY 
function together in SRP protein targeting, Walter and Bradshaw (9) combined reverse-genetics 
with biochemical analysis to study how 4.5S RNA facilitates binding of Ffh and FtsY (the SRP 
receptor) and whether the M-domain of Ffh is involved in Ffh-FtsY complex formation.  Using 
site-directed mutagenesis, they mutated highly conserved regions of the Ffh protein that did not 
inhibit 4.5S RNA binding to Ffh.   Interestingly, they found three mutations, one upstream from 
the finger loop domain and two in the finger loop domain, which impair SRP activity.  They 
observed that in the presence of 4.5S RNA, the rate of complex formation between the mutant 
Ffh and FtsY was greatly reduced; however, they observed that binding was only slightly 
affected when 4.5S RNA was absent.   
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 Very recently, the crystal structure of an Ffh-signal peptide complex was determined by 
Janda et al. (26).  This structure was solved by fusing the ffh gene from Sulfolobus solfataricus to 
the coding sequence for the signal anchor sequence of dipeptidyl aminopeptidase B from yeast.  
These two components were separated by an 11-amino acid linker and the product of this 
chimera was designated SRP54*.  The crystal structure of SRP* revealed the signal sequence 
binds to the hydrophobic groove formed by αM1, αM2 and αM4 and the finger loop is shown to 
form a “lid” above the signal peptide.  Interestingly, the signal sequence was shown to 
extensively interact with αM4 (Figure 1B).  Indeed the binding of this model signal peptide was 
similar to that predicted from previous structural determinations (2, 13, 23, 30, 42, 55).       
The mechanisms of SRP function known to date are primarily the result of biochemical 
and structural analysis.  To better understand how individual components of the SRP, including 
specific domains within the Ffh protein, contribute to SRP function, we have utilized genetic and 
bioinformatic approaches.  The results presented in the following chapters detail these efforts and 
explain how they better inform us as to the function of the SRP. 
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Figure 1.  Structure of the M-domain of Ffh.  (A) Crystal structure of the proposed 
hydrophobic signal sequence binding groove from Thermus aquaticus (Protein Data Bank 2Ffh), 
formed by αM1 (blue), αM2a and αM2b (green), the Finger Loop (purple), and αM4 (red).  Helix 
αM3 (orange) contains the SRP RNA binding domain.  (B) Crystal structure of an Ffh-signal 
peptide complex (Protein Data Bank 3KL4), Ffh from Sulfolobus solfataricus fused to the coding 
sequence for the signal anchor sequence of dipeptidyl aminopeptidase B from yeast.  The signal 
sequence binding groove is formed by αM1a and αM1b (blue), αM2a and αM2b (green), the 
Finger Loop (purple), and αM4 (red).  The signal peptide is shown in yellow.   
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ABSTRACT 
The signal recognition particle (SRP) of Escherichia coli is comprised of the Ffh protein in 
complex with 4.5S RNA.   A unique feature of the Ffh protein is the “finger loop” domain, 
which consists of a largely hydrophobic and unstructured domain exposed near the surface of the 
protein.   Consistent with its predicted role in binding to the hydrophobic signal sequences and 
transmembrane domains of SRP-dependent proteins, we show that the finger loop domain is 
essential for SRP function. To better understand the biological function of this domain, we 
developed a genetic system to screen a random sequence library to identify features of the finger 
loop that are important for its function.  Approximately 1% of the random sequences were able 
to replace the finger loop domain of Ffh in E. coli.   Bioinformatic analysis of the random 
sequences revealed that the single characteristic common to all of the complementing sequences 
was a gradient of decreasing hydrophobicity from the amino-terminus to the carboxy-terminal 
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end.  This trend was also observed by phylogenetic comparisons of finger loop sequences from 
all domains of life.  These observations were further validated by observing that mutations that 
deviated from this trend rendered Ffh nonfunctional.  The random sequence mutants were also 
characterized by growth rates, which allowed the sequences to be grouped into three functional 
classes.  Secondary and tertiary structure predictions suggest that the products of the random 
sequences lack extensive secondary structure, which is consistent with the role of the finger loop 
in binding a variety of ligands.  
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INTRODUCTION 
 
The signal recognition particle (SRP) is a highly conserved ribonucleoprotein complex 
that mediates cotranslational targeting of select polypeptides to the endoplasmic reticulum in 
eukaryotes (52, 53) or the inner membrane in prokaryotes (11, 24, 29, 35).   In eukaryotes, the 
SRP consists of six proteins and a single RNA (7S RNA) (52, 53), which includes a 54-kd 
protein that binds to the RNA and hydrophobic signal sequences (20, 26, 27, 31, 44, 57).   The 
SRP of Escherichia coli is simpler, being composed of the Ffh protein (homologous to the 54-kd 
SRP component in eukaryotes) in complex with 4.5S RNA (42, 43).  The genes encoding Ffh 
and 4.5S RNA (ffs) has been shown to be essential for cell viability (4, 41) and depletion of 
either of these two gene products results in a defect in localization primarily of inner membrane 
proteins (10, 32).  Since E. coli expresses a “minimal” SRP it is an excellent model system to 
study the basic processes of membrane protein biogenesis.     
The mechanism of SRP dependent targeting is similar in bacteria, eukarya and archaea.  
The SRP recognizes and binds to hydrophobic signal sequences of nascent peptide chains as they 
emerge from the ribosome.  The SRP-nascent chain-ribosome complex binds to the membrane 
associated SRP receptor, FtsY in E. coli (19, 33), upon which GTPase activity of both Ffh and 
FtsY triggers the release of the SRP complex to participate in another round of targeting.  
Subsequently, the ribosome complex associates with the translocase, and the peptide chain is 
inserted into or across the membrane (11, 12, 14, 24).  
The Ffh protein is of particular interest because it is the only SRP protein that is 
conserved in every organism.  Both structural (2, 6, 22, 23, 25, 36, 45) and biochemical analysis 
(7) have revealed multiple domains of SRP54 and Ffh that function to recognize and target 
hydrophobic proteins to the cytoplasmic membrane.  Similar to SRP54, Ffh consists of three 
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domains: the amino terminal N-domain, the central GTPase (G-domain), and the methionine rich 
carboxy terminal M-domain.  The N and G domains mediate the binding of SRP with its receptor 
and share sequence and structural homology to similar domains in the SRP receptor, FtsY (33).  
The M-domain of Ffh has been shown through structural analysis and cross-linking studies to 
contain a binding site for 4.5S RNA as well as the primary site of signal sequence binding (31, 
44, 57).  The crystal structure of the M-domain from Thermus aquaticus revealed a deep groove 
formed by three alpha helices and a flexible loop that is lined with hydrophobic residues (25), a 
feature that was subsequently shown to be shared by SRP54/Ffh for a variety of other sources (2, 
6, 22, 23, 25, 36, 45).  It was recently shown that the conserved hydrophobic characteristic of the 
groove forms the signal sequence binding domain of the SRP (23).  However, mechanistic details 
of signal sequence recognition and binding are not yet fully understood. 
A unique feature of the binding groove of Ffh is the flexible loop region termed the 
“finger loop”.  This hydrophobic domain consists of ~20 amino acids that are exposed near the 
surface of the SRP and lacks significant secondary structure.  The finger loop domain is part of 
the predicted binding site for signal sequences and hydrophobic transmembrane domains of 
membrane targeted proteins.  Based upon crystal structures of Ffh/SRP54 from T. aquaticus, E. 
coli, humans and S. solfataricus, the finger loop adopts several different conformations 
suggesting this region of the M-domain modifies its conformation based upon the presence or 
absence of a signal sequence (2, 6, 23, 25, 45).   
To better understand the role of the unique finger loop domain in SRP function we have 
developed a genetic system that allowed selection of sequences from a random sequence library 
that can replace the wild-type finger loop and restore SRP function.  Random libraries have 
previously been used to investigate amino acid sequences important for both protein structure 
32 
 
 
and function (13, 37, 38, 48).  Combined with bioinformatics analyses, we have identified 
heretofore undetected properties of the finger loop domain that are essential for SRP function.   
 
MATERIALS AND METHODS 
Bacterial strains, plasmids and Reagents.  The strains and plasmids used in this study are 
shown in Table 1.  All antibiotics and other chemicals were obtained from Sigma Chemical Co. 
(St. Louis, MO).  Restriction enzymes used for cloning were obtained from New England 
Biolabs (Ispsich, MA) and Fermentas Life Sciences (Glen Burnie, MD).  PCR primers were 
obtained from Integrated DNA Technologies (Coralville, IA).  Antibiotics were used at the 
following concentrations: ampicillin (Amp), 100 µg/ml; chloramphenicol (Cam), 30 µg/ml; 
kanamycin (Kan), 30 µg/ml; spectinomycin (Spc), 100 µg/ml.  
Plasmid construction.  For these studies, we first modified pBADffh6x, a plasmid that expresses 
an allele of ffh that expresses a hexahistidine epitope tag at the carboxy terminus of Ffh (Table 
1).  Plasmid pBADffh6x was first modified using site directed mutagenesis to introduce a NheI 
restriction site at the start of the finger loop coding region, yielding pBADffhN6x (Table 1).  No 
amino acid substitutions resulted from this change.  Plasmid pBADffhN6x∆FL was made by 
PCR amplification using primers ffhNFL.S and ffhNFL.AS (Table 2).  The PCR product was 
digested with NheI and BlpI and the gel-purified DNA was ligated into pBADffhN6x digested 
with the same enzymes.  The resulting plasmid, pBADffhN6x∆FL, expressed Ffh such that the 
gene product was deleted for the finger loop encoding region (amino acids 350-370).  The 
relevant region of each plasmid construct was confirmed by DNA sequencing (DNA Facility of 
Iowa State University).      
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Generate random sequence plasmid library.  A random sequence library (18) was generated 
by synthesizing a randomized oligonucleotide FLrandom.S (Table 2) with an XbaI restriction 
enzyme recognition site at each end.  The DNA was converted to double-stranded by first 
annealing the primer ffhFL2.S (Table 2) and extending the duplex with Klenow enzyme in the 
presence of dNTPs.  The resulting DNA molecules were purified using Qiaex II elution kit 
(Qiagen, Valencia, CA) and digesting with XbaI.  After agarose gel purification the digested 
DNA was ligated to pBADffhFL6x (Table 1) that had been digested with NheI and treated with 
antarctic phosphatase (New England Biolabs, Ispisch, MA).  Ligation reactions were transformed 
into DH5α and plasmid DNA was isolated from pooled transformants.   
Complementation tests.  SLD106 was constructed by transforming PMI105 (Table 1) with 
plasmid pffhTS-Spc, a derivative of a temperature-sensitive cloning vector based on the  
pSC101 origin of replication (40), which confers Spc
R
.  Antibiotic transformants were selected at 
30
o
C and screened for loss of Cam
R
, indication loss of pFfhTS29, which also expresses a 
functional copy of ffh (Table 1). 
The random library was transformed into SLD106, as described by Peterson and Phillips 
(39).  Transformants were plated in duplicate on LB agar plates supplemented with Amp and 
incubated at 30
o
C and 42
o
C.  Transformants were restreaked on LB agar plates supplemented 
with Spc and incubated at 30
o
C to test for Spc
S
, indicating loss of the temperature-sensitive 
plasmid. Plasmid DNA was isolated using a Qiagen miniprep kit (Qiagen, Valencia, CA) and the 
DNA sequences of the ffh alleles determined. 
Sequence analysis.  The multiple alignment tool Clustal W (49) was used to align the finger 
loop sequences of 109 Ffh/SRP54 proteins representing multiple species (1), as well as the 
predicted amino acid sequences of each mutant.  ExPASy (Expert Protein Analysis System) 
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proteomics and sequence analysis tool, ProtScale (17), was used to determine the hydrophobicity 
across the finger loop sequences.  ProtScale parameters used to generate hydrophobicity plots 
included using the Kyte and Doolittle scale and a sliding window of size 5.  Additionally, 
hydrophobicity plots were re-generated and compared using Microsoft Office Excel 2007.    
Predict Protein (Structure Prediction and Sequence Analysis Service) (54) was used to generate 
secondary structure predictions.  The homology modeling server CphModel Server 2.0 (30) was 
used to generate 3D predictions of the mutant sequences and each predicted model was viewed 
using the molecular visualization software RasMol.   
Construction of additional finger loop mutants.   Four additional finger loop mutants were 
constructed using PCR (LM-AA, LM-SS) or by replacing relevant regions of the finger loop 
sequence with oligonucleotides (PG-AA, DNK-LQL).  To construct the LM-AA and LM-SS 
alleles, pBADffhN6x as a template for PCR using primers ffhFL-LM-AA.S, ffhFLAS.AS and  
ffhFL-LM-SS.S, ffhFLAS.AS, respectively (Table 2).  Gel purified PCR products were digested 
with NheI and SacI and ligated into pBADffhN6x digested with the same enzymes.  
 To construct the PG-AA, two complementary oligonucleotides (Table 2) were 
synthesized and mixed at a 1:1 molar ratio.  The DNA was heated to 75
o
C followed by slow 
cooling to room temperature resulting in a double stranded molecule with 4-base overhangs 
compatible with the NheI restriction site.  The DNA was ligated into pBADffhN6x that had been 
digested with NheI and treated with antarctic alkaline phosphatase (Fermentas Life Sciences, 
Glen Burnie, MD).  Ligation reactions were digested with NheI to further reduce the background 
of recircularized plasmids.  A similar strategy was used to construct the DNK-LQL allele, using 
oligonucleotides ffhFL-DNK-LQL.S and ffhFL-DNK-LQL.AS (Table 2).  All recombinant 
plasmids were confirmed by DNA sequencing. 
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Growth characterization of finger loop mutants.   To characterize growth of the finger loop 
mutants, SLD108 was constructed.  This strain is deleted for genes whose products are necessary 
for arabinose transport (araFGH, araE) and utilization (araBAD).  In addition, SLD108 
expresses a mutant LacY permease that allows homogenous uptake of arabinose throughout the 
population (3, 34).  As a result, arabinose acts as a true gratuitous inducer and the heterogeneity 
of gene expression of genes under araC control is eliminated in SDL108 (34).  To construct 
SLD108, ECF529 (3) was first modified by lambda Red homologous recombination to inactivate 
bla (Amp
R
), encoded on the chromosome, by replacement with a Kan
R
 gene cassette amplified 
from pKD4 (9).  The gene cassette was subsequently deleted using Flp-mediated site-specific 
recombination (9).  The resulting Kan
S
 strain, XLU102 (Table 1) was subsequently transformed 
with pffhTS-Spc, and the ffh::kan1 allele introduced by P1 transduction (39).  Like SLD106, 
SLD108 is inviable at 42
o
C since the sole functional copy of ffh is expressed from a temperature-
sensitive plasmid.   
 Plasmids expressing functional finger loop mutants and control plasmids were 
transformed into SLD108 and Amp
R
 colonies restreaked on LB+Amp agar plates and incubated 
at 42
o
C.   Single colonies were used to inoculate 5 ml of LB agar and grown at 42
o
C for 12 h.  
500 µl of the overnight cultures were transferred to 50 ml of LB medium and grown at 42
o
C to 
an OD600 0.5-0.6.   Cultures were diluted to 10
-8
 and spotted onto 3.5 x 3.5-inch square plates 
containing LB+Amp media and supplemented with L-arabinose at concentrations of: 0.0002%, 
0.002%, 0.004%, 0.006%, 0.008% and 0.02%.  Plates were incubated at 30
o
C for 12 h.     
Bioscreen C assay to classify sequences.  The kinetics of growth of the mutants was determined 
using a Bioscreen C Automated Growth Curve Analysis System (Growth Curves USA, 
Piscataway, NJ).  Mutants were transformed into SLD108 and transformants were restreaked on 
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LB+Amp agar plates and incubated at 42
o
C for 12 h.  Single colonies from each mutant was 
inoculated into LB+Amp broth (1 ml), loaded into individual wells in a 96 well plate and 
incubated in a 42
o
C water bath with shaking for 12 h.  Overnight samples were diluted 1:l00, 
added to 250 µL of LB+Amp medium and loaded in triplicate into bioscreen micro-plates (10x10 
wells).  Bioscreen C conditions were programmed to maintain a constant growth temperature of 
42
o
C and to record the OD600 of each sample every 15 min over 24 h.  Subsequently, growth 
curves were plotted and the growth rate constants were determined and analyzed using Microsoft 
Excel.    
Detection of Ffh mutant proteins.  Plasmids pBADffhN6xFL-PG-AA, pBADffhN6xFL-LM-
AA, pBADffhN6xFL-LM-SS, pBADffhN6xFL-DNK-LQL along with the wild type control 
pBADffhN6x were transformed into SLD106.  Cells were grown at 30
o
C in LB+Amp to mid-
logarithmic phase and subsequently induced with arabinose.  Upon reaching an OD600 of ~0.6, 
500 µl of culture was pelleted at 13,000 rpm in a microcentrifuge. The pellets were resuspended 
in 100 µl of nanopure water. 40 µl of the suspension was mixed with 38 µl of Laemmli sample 
buffer (Bio Rad, Hercules, CA) and 2 µl of β-mercaptoethanol.  Samples were heated for 5 
minutes at 95
o
C, and then recentrifuged before loading a portion of the supernatant on two 12% 
polyacrylamide gels.  Proteins were detected on two different gels using either the Bio-Safe 
Coomassie G-250 Stain (BioRad, Hercules, CA) or InVision His-Tag In Gel Stain (Invitrogen, 
Carlsbad, CA), which was used to detect the a hexahistidine epitope tag at the carboxy terminus 
of Ffh.   
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RESULTS                                                                                                                                     
The finger loop domain is essential for Ffh function.   To characterize the finger loop domain 
of Ffh, we first constructed SLD106 to facilitate performing complementation tests (Materials 
and Methods).   As shown in Fig. 1A, this conditional strain grows at 42
o
C only if it is 
transformed with a plasmid expressing a functional copy of ffh.  For this, we used pBAD-ffhN6x, 
a ColE1-derivative plasmid that expresses ffh under control of the araBAD operator and 
promoter (Table 1).  Ffh is expressed from this plasmid with a hexahistidine epitope tag on the 
C-terminus which was shown previously not to interfere with SRP function (39).  To determine 
the importance of the finger loop domain for Ffh function, we used site-directed mutagenesis to 
modify pBADffhN6x by deleting a 60-bp region that encodes the finger loop (56), yielding 
pBADffhN6x∆FL (Table 1 and Fig. 1A).  
In characterizing the wild type control (expressed from pBADffhN6x, Table 1), we 
observed, conveniently, that arabinose was not needed to complement ffh::kan1 in SLD106 when 
grown at 42
o
C, apparently due to leaky expression from the araBAD promoter at the elevated 
growth temperature.  Previous studies (43), as well as our own observations, revealed that 
elevated expression of Ffh is detrimental to cell growth, i.e., Ffh over expression exerts a 
dominant negative phenotype.  Similar to wild type, E. coli expressing increased levels of 
Ffh∆FL from pBADffhN6x∆FL grew poorly, indicating that other features of the protein are 
important for the dominant negative phenotype (data not shown).  In contrast to the wild type 
control, however, expression of ffh∆FL failed to complement ffh::kan1 in SLD106 at 42oC (Fig. 
2A and 2B).                                                                                                                                            
Sequence analysis of FL from multiple species.  The finger loop domain is unstructured in 
SRP crystallographic studies (11), and most of the amino acids within this region are not highly 
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conserved.   To determine the extent of sequence conservation in the finger loop, we compared 
amino acid sequences from this domain from 109 distinct species, representing all 3 domains of 
life using a multiple sequence alignment (49).  We found two amino acids, Pro-355 and Gly-356 
from E. coli, were highly conserved (data not shown).    
Selection of random sequences that restore finger loop function.  Based upon the results of 
our sequence comparisons across multiple species, we chose to select random sequences that 
could restore function to the ffh∆FL mutant as a means to investigate the features of the finger 
loop domain important for Ffh activity.  As summarized in Fig. 1B, we generated a library of ffh 
variants where the 60-bp region encoding the finger loop was replaced by randomized bases.  To 
isolate functional ffh mutants, we introduced the random sequence library into SLD106 and 
selected transformants that grew at 42
o
C (Fig. 1).   
 To eliminate false positives, we tested each transformant that grew at 42
o
C for Spc 
sensitivity, indicating loss of pffhTS-Spc.  Each Spc
S
 transformant was further tested to confirm 
its ability to grow at 42
o
C (Fig. 2B).  By comparing the efficiency of transformation at 30
o
C and 
42
o
C we estimated that ~1% of the total number of random sequence inserts were capable of 
restoring function to the ffh∆FL mutant.  Of these, 42 complementing clones were selected for 
further characterization.  
Growth assays to classify functional finger loop sequences.   In other studies where ffh 
mutants were characterized, we observed a correlation between SRP function and growth rates 
(Duncan and Phillips, manuscript in preparation).  While performing complementation tests of 
the finger loop mutants we observed differences in colony sizes among the complementing 
clones.  To quantify the differences in growth rate reflected by colony sizes, we used a Bioscreen 
C Automated Growth Curve Analysis System to determine growth rate constants.  From these 
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results we were able to divide each of the complementing finger loop clones into three distinct 
groups based on their growth rates (Fig. 3).  
As an independent means to measure bacterial growth, we also took advantage of the 
ability to regulate expression of ffh with arabinose to determine the amount of inducer needed for 
each finger loop clone to complement ffh::kan1.  For this, SLD108 was constructed by using a 
genetic background that allows homogeneous cell-to-cell expression in the presence of different 
arabinose concentrations (34).  SLD108 was transformed with each finger loop clone and grown 
at 42
o
C to cure the cells of pffhTS-Spc.  Spc
S
 transformants were then cultured at 30
o
C on 
LB+Amp plates in the presence of different concentrations of arabinose. We observed a general 
trend that finger loop mutants with smaller colony sizes and slower growth rates required a 
higher concentration of arabinose to support growth (Fig. 3).  As explained above, arabinose 
concentrations above 0.001% were detrimental to cell growth.  Taken together, these results 
indicate sequences that function poorly as finger loop replacements required higher levels of 
expression than sequences that function at near wild type levels (Fig. 3).     
Sequence analysis of finger loop clones.  The DNA sequences of 42 complementing mutants 
were determined.   The predicted amino acid sequences encoded by each random sequence are 
shown in Table 3.  Each amino acid sequence was examined for several properties for 
comparison with the wild type finger loop sequence from E. coli.   
 Initially, finger loop sequences were analyzed using multiple alignment tools, including 
ClustalW (49), to compare the complementing mutants.  We failed to observe a correlation of 
amino acid conservation or distribution at any of the residue positions between wild type and 
mutant finger loop sequences (Table 3).  Since the finger loop is unusual in that it is an exposed 
hydrophobic domain (1), we analyzed the random sequences using hydrophobicity plots to 
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determine the distribution of hydrophobic amino acids across the finger loop from amino (N)-
terminus to carboxy (C)-terminus.  From these plots we observed that, like the E. coli finger 
loop, all of the complementing sequences consistently progressed from high hydrophobicity at 
the N-terminus to significantly lower hydrophobicity towards the C-terminus (Fig. 4A).  
Although the data in Fig. 4A utilized the Kyte-Doolittle scale (28), this trend held when other 
hydrophobicity scales where also tested (15, 16, 21) (Materials and Methods).  In addition, 
although the overall trend across the finger loop was toward less hydrophobicity, a periodicity 
alternating between hydrophobic and hydrophilic values was also observed in the wild type 
finger loop sequence from E. coli; however, the periodicity was not as apparent in the sequences 
of the functional clones when analyzed collectively using the average hydrophobicity.  
 To determine if the trend from more to less hydrophobicity, as well as the periodicity of 
the residues, was conserved across phylogenetic lines, we re-examined the multiple alignment 
previously generated to compare the finger loop domain from 109 Ffh sequences from multiple 
species, representing all three domains of life (1).  We used ExPASy sequence analysis tool 
ProtScale (17) to generate hydrophobicity plots to observe the distribution of hydrophobic amino 
acids within the finger loop from multiple species.  Similar to the functional random sequences, 
we observed the progression of more to less hydrophobicity from N- to C-terminus is 
phylogenetically conserved, as was the alteration between hydrophobic and hydrophilic amino 
acids observed in the wild type finger loop sequence from E. coli (Fig. 5).   Furthermore, our 
sequence analysis revealed that there is significant sequence variation in the finger loop domain 
from multiple species toward the C-terminus; however, the physicochemical properties of the 
amino acids are similar.  Using Jalview 2.4.0 (5, 55) and WebLogo (8, 47), a consensus sequence 
was determined based upon the conservation of these properties (Fig. 5 and Table 3).  
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 To determine what features encoded by the random sequences are most important for 
optimal function of Ffh, hydrophobicity plots were generated for each of the three groups of 
functional finger loop mutants (Fig. 4B).  Although the trend from high to low hydrophobicity 
was conserved among the groups, there was a marked difference in the average hydrophobicity 
of each group at several amino acid positions (Fig. 4B).  Specifically, the average hydrophobicity 
of the residues at several positions (2, 6, 7, 9, 10, 13, 15, and 17) were more similar between 
group I sequences and the wild type sequence.  Group II sequences were more similar to wild 
type than sequences from group III at positions 1, 11 and 17.  Group I sequences also more 
prominently revealed the periodicity observed with the wild type finger loop sequence of 
alternating between hydrophobic and hydrophilic residues.  These observations reveal that the 
hydrophobicity of each amino acid position throughout the finger loop is more important for Ffh 
function than specific amino acid identity. 
 Sequence analysis revealed that the finger loop from multiple species contained highly 
conserved Pro and Gly residues (Table 3).  Although the majority of the complementing finger 
loop sequences possess either a single or multiple Pro or Gly residues, they are not found at 
consistently conserved positions.  Additionally, not all of the functional random sequences 
require Pro or Gly residues.  For example, finger loop sequences II-12-5, II-12-7 and II-701-7 
lack a Pro or Gly residue; both are members of group II by complementation tests (Table 3).      
Additional sequence analysis.  We further analyzed the mutant finger loop sequences to detect 
potential secondary structure by using PredictProtein (46).  Our results reveal that all functional 
sequences lacked significant secondary structure, consistent with structural and biochemical 
analysis of Ffh (2, 6, 7, 22, 23, 25, 36, 45).  Subsequently, we used DisEMBL and DISOPRED2 
(54) to predict if the finger loop mutants, like wild type, are disordered in the Ffh protein.  
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Results revealed that each of the mutants has an increased probability to be a disordered region 
in Ffh (data not shown).  
 From the crystal structure of the Ffh proteins from Thermus aquaticus (25) and 
Sulfolobus solfataricus (23), a short alpha-helical region in the finger loop domain was detected.  
To test if any of the sequences from the complementing mutants were predicted to form a similar 
structure or additional structure, we used CphModel Server 2.0 (30) to predict the 3-D structure 
from both the complementing mutants.  Each of the functional finger loop mutants was predicted 
to contain the short alpha-helical region detected in T. aquaticus and S. solfataricus, however, no 
additional structure was predicted.   
Functional characterization of the finger loop domain.  The importance of multiple features 
of the finger loop revealed from analysis of the random sequences was directly tested.  First, to 
test the importance of hydrophobic amino acids at the extreme N-terminus, we used site-directed 
mutagenesis, as described in Materials and Methods, to construct mutants where the first two 
hydrophobic residues were replaced with either alanine (L350A and M351A) or serine (L350S 
and M351S).  As shown in Fig. 2C and 2D, both mutations rendered ffh non-functional.  Next, 
the contribution made by the “gradient” of hydrophobicity through the finger loop on Ffh 
function was tested by replacing three C-terminal amino acids with hydrophobic residues 
(D362L, N363Q, K365L).  This mutant also failed to complement ffh::kan1 (Fig. 2C and 2D).   
Site directed mutagenesis was next used to construct additional mutants where the 
conserved proline and glycine were replaced with alanine (P355A and G356A) to assess the 
importance these amino acids in Ffh function.  As shown in Fig. 2D, this mutant again rendered 
Ffh non-functional.  To confirm that Ffh was being synthesized in each of the mutants we took 
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advantage of a hexahistidine epitope tag present at the C-terminus of the full length Ffh protein 
to visualize each polypeptide by SDS-PAGE (Fig. 6).   
Although the hexahistidine tag was shown not to interfere with Ffh function when 
expressed from pBADffhN6x, we also tested each of the finger loop mutants when expressed 
without the epitope tag.  For these studies we constructed plasmid derivatives to express the Ffh 
mutants without the hexahistidine epitope tag.  Even when expressed without the epitope tag, 
none of the mutants tested complemented in SLD106 (data not shown).  However, elevated 
expression of each of the specific finger loop mutants at the highest concentrations of arabinose 
significantly inhibited growth, indicating that all expressed mutant Ffh protein.    
 
DISCUSSION 
 
 The crystal structure of the Ffh M-domain from Thermus aquaticus (25) as well as the 
full length Ffh proteins from other species (2, 6, 22, 23, 36, 45) consistently revealed the M-
domain consists of anywhere from four (in T. aquaticus) to seven (in Human SRP) α-helices 
with the predicted signal sequence binding groove formed by several of these helices in 
combination with the flexible finger loop domain.  Most recently, the structure of a signal 
peptide bound to this hydrophobic groove was presented, confirming the importance of this 
feature of the protein (23).  In this structure of Sulfolobus solfataricus, the finger loop appeared 
to participate in signal peptide binding by forming a “lid” on top of the signal sequence binding 
domain (23).  Consistent with this important role in signal sequence binding, we showed that the 
finger loop is essential for Ffh function, hence viability of E. coli (Fig. 2A and 2B). 
 Initially, to identify amino acid residues that might be conserved in the finger loop 
domain, we used using multiple sequence alignments to compare 109 finger loop sequences from 
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multiple species.  From this, two residues, (Pro-355 and Gly-356 from E. coli) were found to be 
highly conserved in the finger loop; however, most of the amino acid positions throughout the 
finger loop domain were variable.  
 As an independent approach to identify specific features of the finger loop essential for 
Ffh function we selected random sequences that were able to functionally replace the finger loop.  
The use of random sequence libraries has been used for various applications such as determining 
residues that contribute to protein or enzyme function and structure as well as to select for new 
mutants that vary in biological activity, such as binding alternate proteins and receptors (13, 37, 
38, 48).  Characterization of random sequences with biological function have effectively been 
used to identify characteristics of signal sequences found in secretory proteins (37), as well as to 
identify important amino acids for DNA Pol I (38, 48).  To apply this approach to characterize 
Ffh, we screened a random sequence library generated by randomizing 20 residues in the finger 
loop domain and selecting clones capable of complementing the ffh deletion mutant in SLD106 
(Fig. 1).  Our results revealed that a surprisingly high number (~ 1%) of randomly generated 
sequences were able to replace the finger loop domain of Ffh, of which 42 independent clones 
were selected for further analysis. 
 Although all of the selected clones encoded functional Ffh protein, we observed 
differences in growth, as initially measured by colony sizes, indicating the mutants functioned at 
different levels of efficiency.  As a result, growth differences were quantified by determining 
growth rate constants for each mutant.  From this data, we partitioned the complementing clones 
into three groups (Table 3).  To further characterize these mutants, we reasoned that mutants 
displaying a slower growth rate should require increased concentrations of arabinose since 
expression of the alleles was regulated by the araBAD operator and promoter.  As shown in 
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Table 3, our prediction was confirmed as we found that, in most cases, mutants displaying slow 
growth rates needed increased amounts of arabinose to support cell viability (Fig. 3).   
 To identify amino acids that may have been conserved at specific positions along the 
finger loop sequences of our complementing mutants, multiple sequence alignments were 
performed; however, no specific amino acids were consistently found at any of the positions 
(Table 3).  Additionally, although Pro and Gly residues are highly conserved in the finger loop 
domain in nature, this conservation was not held among the random sequences (Table 3). 
 Since the finger loop is largely hydrophobic (2, 6, 7, 22, 23, 25, 36, 45), we next 
generated hydrophobicity plots using ExPASy sequence analysis tool ProtScale (17) using 
several different hydrophobicity scales (15, 16, 21, 28) to examine the frequency and distribution 
of hydrophobic amino acids in the mutants.  This approach revealed a trend of increased 
hydrophobicity at the N-terminus and a decrease in hydrophobicity at the C-terminus in the 
finger loop mutants, as well as in the wild type sequence from E. coli (Fig. 4A).  Furthermore, 
we observed in the wild type sequence and in 80% of the sequences of the complementing 
clones, a periodic distribution of hydrophobic amino acids.  As shown in Fig. 5, the trend toward 
less hydrophobicity was also shared among the three groups of functional finger loop sequences 
and the periodicity of alternating hydrophobic/hydrophilic amino acids was observed, albeit to a 
lesser extent, in the amino acid sequences that comprised group I.  These results suggest that 
although the periodicity may be important for optimal function of the finger loop, it is not an 
absolute requirement.     
 The importance of the trend from high to low hydrophobicity was further supported by 
observing the same relationship among Ffh sequences from multiple species (Fig. 5).  
Hydrophobicity plots revealed phylogenetic conservation of the hydrophobic trend observed in 
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the functional finger loop random sequence mutants as well as the periodicity of the hydrophobic 
residues found in the wild type finger loop sequence (Fig. 5).   Additionally, although there is 
little sequence homology among the finger loop sequences from complementing clones as well 
as different species, we observed a similarity in the physicochemical properties of the residues 
among sequences from different species, as shown in the consensus sequence (Table 3 and Fig. 
5).  Here, we see that the N-terminus contains conserved hydrophobic amino acids (positions 1, 
2, 5 and 8), residues whose properties vary (positions 11-15) and the C-terminus is comprised of 
polar amino acids (positions 16-20).   Differences in several amino acid positions among the three 
groups of finger loop mutants (Fig. 4B) were observed when we compared the average 
hydrophobicity of each group.  We found that although the identity of the residues themselves 
varied, the hydrophobicity of amino acids found at key positions in the mutant sequences 
correlated with those found in the corresponding positions in the wild type finger loop.  These 
results indicate that the chemical properties of the amino acids at selected positions, rather than 
the identity of the amino acids themselves, is the key determinant for function of the finger loop 
domain.  This feature is consistent with a role of the finger loop in recognition of hydrophobic 
signal sequence as it is well established that signal sequences also vary in amino acid 
composition while retaining a hydrophobic nature (50, 51, 56).  We further note that the 
sequences represented by the group I mutants more closely resembled wild type with respect to 
the overall trend in reduced hydrophobicity from N- to C- terminus, as well as the 
hydrophobic/hydrophilic periodicity of the residues (Fig. 4B).  
To test the importance of hydrophobicity in finger loop function, we constructed a series of 
mutants that altered specific features in this domain predicted to be important based on the 
random sequence analysis.  This included mutants with reduced hydrophobicity at the N-
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terminus (L350A, M351A) and (L350S, M351S), increased hydrophobicity toward the C-
terminus (D362L, N363Q, K365L).  None of the mutants supported cell viability, confirming the 
importance of the hydrophobic trend discovered with the complementing random mutants.  In 
addition we altered the conserved Pro and Gly residues (P355A and G356A) to test the 
importance of these amino acids.  This mutant also failed to support Ffh function. With this in 
mind, we determined the distribution of each of these residues in the mutant finger loop 
sequences.  We found that, while the majority of the random sequences included Pro and Gly at 
various positions throughout the sequence, some sequences lacked these residues.  This suggests 
that Pro and Gly are not required for Ffh function when found in combination with other 
residues.     
Consistent with structural and biochemical analysis of Ffh that revealed the finger loop 
domain is unstructured (2, 6, 7, 22, 23, 25, 36, 45), the functional finger loop mutants were also 
predicted to lack secondary structure and disordered in the Ffh protein (46, 54).    Although the 
finger loop was predicted to be largely unstructured, the crystal structure of Ffh from Thermus 
aquaticus (25) and Sulfolobus solfataricus (23) revealed a short α-helix contained at the 
beginning and the center of the finger loop domain.  Based upon the predicted 3-D structure of 
each mutant (30), a difference between the predicted structure of our functional finger loop 
mutants and the crystal structure from T. aquaticus, was not observed, indicating this is not likely 
an essential feature of the finger loop in all sources of Ffh.    
 To detect additional patterns in the finger loop sequences from complementing clones 
that could reveal important features of the domain, we examined the distribution of amino acids 
based upon size, charge, polarity and propensities toward secondary structure.  No additional 
properties common to all of our functional finger loop sequences were observed, however.   
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 In conclusion, this study provides another example of how screening of random sequence 
libraries can yield new insights into biological function.  This approach has revealed that while 
the finger loop is extremely tolerant of amino acid substitutions, it maintains a strict requirement 
for hydrophobicity only at the N-terminal region of the domain.  Future studies will include 
biochemical analysis of the products of the mutants to more precisely identify how changes to 
the finger loop affect SRP function.  
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Fig. 1.  (A) Genetic system for screening a random sequence library for complementing 
clones.  The random library was transformed into SLD106 by selecting Amp
R
 at 42
o
C.  
Transformants were re-tested for their ability to complement the ffh deletion in SLD106, and for 
Spc
s
, indicating loss of the temperature-sensitive plasmid in this strain. (B) Synthesis of random 
sequences for library construction.  An oligonucleotide containing randomized codons was 
synthesized and converted to a double-stranded molecule, as described in Materials and 
Methods.  The DNA was digested with XbaI and ligated to pBAD-ffhN6X at a unique NheI site 
engineered in place of the finger loop-encoding region.   
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Fig. 2.  Phenotypes of ffh finger loop mutants.  (A) Colonies grown at 30
o
C showing positive 
(ffh
+
) and negative (ffh FL) controls and examples of 3 mutants (1, 2 and 3).  (B) Colonies 
restreaked at 42
o
C from (A) showing complementation by mutants 1, 2 and 3, and ffh
+
.  (C) 
Colonies grown 30
o
C showing positive (ffh
+
) and negative (ffh FL) controls and mutants ffhAA 
(L350A and M351A), ffhSS (L350S and M351S), PG (P355A and G356A) and HM (D362L, 
N363Q, K365L).  (D)  Colonies restreaked at 42
o
C from (C) showing complementation by only 
ffh
+
.   
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Fig. 3.  Phenotypic classification of finger loop mutants.  Growth rates of each mutant were 
calculated as a ratio of the mutant growth rate constant (GRC) /wild type growth rate constant, as 
indicated on the left ordinate. Mutants were partitioned into three functional groups (I, II and III) 
based upon these ratios.  The concentration of arabinose required for growth of each mutant 
(right ordinate) is indicated by the red line. As shown, finger loop mutants with reduced growth 
rates in comparison with wild type, in general, required a higher concentration of arabinose to 
support growth.   
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Fig. 4.  Hydrophobicity plot of finger loop domain.  (A) Comparison of the hydrophobicity 
values of E. coli Ffh (black line) with the average hydrophobicity of the 42 complementing 
sequences (blue line).  Also shown is the average hydrophobicity at each position of a truly 
random sequence (grey line).  (B)  Comparison of the average hydrophobicity of each mutant 
group (I, purple line; II, blue line; III, grey line) and the hydrophobicity of wild type Ffh finger 
loop domain (black line).  Hydrophobicity was determined by ProtScale using the Kyte-Doolittle 
scale.  
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Fig. 5.  Hydrophobicity plot of finger loop domain.  Comparison of the hydrophobicity values 
of the finger loop domain from a subset of multiple species representing all three domains of life 
(blue line) with the average hydrophobicity of the 42 complementing sequences (purple line).  
The hydrophobicity of the finger loop domain from E. coli Ffh is also shown (black line).  A 
consensus sequence displaying the conserved physicochemical properties or conserved residues 
for each amino acid position are indicated at the top of the graph, where H=Hydrophobic, 
P=Polar and V=Variable.  Jalview 2.4.0 and WebLogo were used to determine the consensus 
sequence and hydrophobicity was determined by ProtScale using the Kyte-Doolittle scale.   
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Fig. 6.  Expression of finger loop mutants in vivo.  (A) SDS-PAGE of total cell lysates 
expressing wild type Ffh (lane 1) and finger loop mutants L350A/M351A (lane 2), L350S/ 
M351S) (lane 3), D362L/N363Q/K365L (lane 4) and P355A/G356A (lane 5), where expression 
of ffh was induced by L-arabinose. (B) Detection of Ffh by His-tag stain, as described in 
Materials and Methods.   
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Table 1: Strains and plasmids used in this study 
Strain of plasmid Relevant genotype or description Source or 
Reference 
E. coli strain   
 NEB5α  fhuA2Δ(argF-lacZ)U169 phoA glnV44 80 
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
(general cloning host) 
New England 
Biolabs 
 MC4100 F
-
 araD139, Δ(argF-lac)U169, rspL150, relA1, 
flbB5301, fruA25, deoC1, ptsF25 e14- 
Lab collection 
 PMI105 MC4100, ara
+
, ffh::kan1, Δ recA-srl)306 srl-
301::Tn10-84, pFfhTS29 (Cam
R
) 
Lab collection 
 SLD106 PMI105, ffh::kan1, pFfhTS-Spc (Spc
R
) (Tet
R
) This study 
 ECF529 ΔaraBAD, ΔrhaBAD, ΔaraFGH, ΔaraE,  
rrnBPI(CTC-AGA)-lacYA177C 
(3) 
 XLU102 ECF529, bla:: Δkan Lab collection 
 SLD108 XLU102, ffh::kan1, pffhTS-Spc This study 
Plasmid   
 pffhTS-Spc 
 
pSC101ts, ffh
+
, spc (Spc
r
) Lab collection 
 pBADffh6x Vector for expression of ffh under ParaBAD control, 
araC, bla (Amp
R
) 
(39) 
 pBADffhN6x pBADffh6x (NheI) This study 
 pBADffhN6xΔFL pBADffh6x, ParaBAD-ffh ΔFL(NheI) This study 
 pBADffhN6xFL* pBADffhN6xΔFL plasmid series with random 
sequence insertions shown in Table 3. 
This study 
 pBADffhN6xFL-PG-
AA 
pBADffh6x, PG to AA mutations This study 
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Table 1: (continued) 
Strain of plasmid Relevant genotype or description Source or Reference 
Plasmid   
 pBADffhN6xFL-LM-AA pBADffh6x, LM to AA mutations This study 
 pBADffhN6xFL-LM-SS pBADffh6x, LM to SS mutations This study 
 pBADffhN6xFL- DNK-LQL pBADffh6x, D-L,N-Q,K-L mutations This study 
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Table 2: PCR primers and oligonucleotides 
Primer or 
oligonucleotide name 
Sequence (5'--3') 
FLrandom.S GACTGACTTCTAGA (NNK)20 TCTAGATCAGTCAGTCAG 
ffhFL2.S TCTAGATCAGTCAGTCAG 
ffhNFL.S ATGGCTAGCAAAGTGCTGGTGCGTATGGAAGCC 
ffhNFL.AS CCCCCAGGCTTCCCTGGTCGC 
ffhFL-LM-AA.S AGCTAGCGCAGCCGGCAAGCTGCCGGGCATGGG 
ffhFL-LM-SS.S GGCTAGCTCCTCGGGCAAGCTGCCGGGCATGGG 
ffhFLAS.AS GAGCTCGCGACCAGGGAAG 
ffhFL-DNK-LQL.S CTA GTC TGA TGG GCA AGC TGC CGG GCA TGG GGC AGA 
TCC CGC TGC AGG TCC TGT CAC AGA TGC TGA 
ffhFL-DNK-LQL.AS CTA GTC AGC ATC TGT GAC AGG ACC TGC AGC GGG ATC 
TGC CCC ATG CCC GGC AGC TTG CCC ATC AGA 
ffhFL-PG-AA.S CTAGTCTGATGGGCAAGCTGGCCGCCATGGGCAGATCCCG
GATAACGTCAAGTCACAGATGGACGATA 
ffhFL-PG-AA.AS CTAGTATCGTCCATCTGTGACTTGACGTTATCCGGGATCTG
CCCCATGGCGGCCAGCTTGCCCATCAGA 
Restriction enzyme sites are shown in bold 
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Table 3. Summary of finger loop mutant sequences and growth data 
Finger loop mutant Amino acid sequence Growth rate constant
1
 
Consensus Sequence
2
 HHPMHPGHPPVVVVVPPPPP  
Complementing Mutants   
GROUP I   
Wild Type LMGKLPGMGQIPDNVKSQMD 1.28 
I-408-5 HMWPGLLCRYASGNVTDVVI 1.25 
I-409-3 KLAKTWDVAMNLEGSAGAVE 1.24 
I-17-3 VVKLAQYKGVRVMESTEHNG 1.22 
I-87 ILPLLPTRTILHQRSNPISD 1.22 
I-12-14 QLHQILMPNTPLPPSTTHQQ 1.19 
GROUP II   
II-703-13 LLAYMPSGHFMMRHVQGERE 1.15 
II-21-7 LMKLRNTRIQSNQTITLHHL 1.13 
II-19-8 IIQKLPHQMSTIQHIIPPPN 1.12 
II-12-22 LCNWIVTHGLSRKGGAIQTE 1.10 
II-3-1 FLAARSGNKSIPLSLRSEGG 1.10 
II-12-1 VLAYLPYVSGMQSTGVWFGE 1.08 
II-12-7 LFNFRESTSKKEAEGTTVPD 1.06 
II-12-19 VIMEYGQMLAGTANVMSETQ 1.06 
II-S2-3 IGELINQRMTGIYLHSCQRE 1.06 
II-405-1 LLPKPHRHPLTPPTKHPISQ 1.06 
II-S13-1 LMSWLRPFRARKGAHGFGSE 1.06 
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Table 3. (continued) 
Finger loop mutant Amino acid sequence Growth rate constant
1
 
GROUP II   
II-S13-2 LINRIQPPHKQTPPSQIHQN 1.05 
II-8-8 VMELYQGLGGTRPDPRDSDQ 1.05 
II-1-1 LLLPSMRLRTPKMRTTIPTP 1.04 
II-402-1 LSIFLGSKLRFDQSDLFPDE 1.03 
II-409-5 LISHTHTQHLLSTTPIRPQP 1.02 
II-704-3 DLWNLMAAQGTKRRANRRDK 1.01 
II-12-3 IIPLLPLPNTRPSIRNPQPT 1.01 
II-26-18 ILELFAIEPKRMKRGTERCN 1.00 
II-901-2 YAGHWAPARSASEKLLCVKD 1.00 
II-12-5 FIQSLDRRMADHRYVSTCDE 1.00 
II-701-11 ILQLPPSSIRLNTKQLPPTP 0.98 
II-12-4 WGVKLVRTPGGRFLEPEVEA 0.97 
II-701-7 FMDQLIEDNSCRRQTQHRIS 0.96 
II-12-8 LMSLLRPQHINMNPLTQHIS 0.93 
II-6-1 MIITSGGGPQTRGSTSGECS 0.92 
II-19-1 LMTHQMTHTPTNLRNTNPIT 0.92 
II-402-4 LMPMTRTPHPIKTLSTLNNQ 0.90 
GROUP III   
III-707-9 FLGRCMPRSSTGMDGSPDDR 0.85 
III-10-1 FAFIGRLSPVRPLRTVSTGQ 0.82 
III-19-13 VRGFLSCGKTTQTNCDWASE 0.82 
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Table 3. (continued) 
Finger loop mutant Amino acid sequence Growth rate constant
1
 
GROUP III   
III-707-9 FLGRCMPRSSTGMDGSPDDR 0.85 
III-10-1 FAFIGRLSPVRPLRTVSTGQ 0.82 
III-19-13 VRGFLSCGKTTQTNCDWASE 0.82 
III-707-7 YFGSTVNIPNNEMGAMEPQK 0.80 
III-904-2 LLNQTTPSRIHRSPLQRRQQ 0.77 
III-100-1 LLPRTTNRRHVGRHWVEPGY 0.73 
III-16-1 ALQTIGSNVGPEDFTKVDNQ 0.68 
III-19-19 VLDMLVSNTQEMTRGLERSD 0.63 
III-402-5 RLGVSNTQSSDNASPREHIN 0.59 
Non-Complementing Mutants   
PG-AA LMGKLAAMGQIPDNVKSQM  
LM-AA AAGKLPGMGQIPDNVKSQM  
LM-SS  SSGKLPGMGQIPDNVKSQM  
DNK-LQL LMGKLPGMGQIPLQVLSQM  
1
Growth rate constants for each mutant were determined as described in Materials and Methods.  
Mutants were classified as described in the legend to Fig 4.  Hydrophobic amino acids Leu-Met 
in the wild type finger loop are shown in bold, while the conserved Pro-Gly is underlined in the 
wild type sequence. 
2
A consensus sequence showing the conserved physicochemical properties or conserved residues 
for each amino acid position in the finger loop are indicated at the top of the table where 
conserved Methionine (M) is shown in bold, conserved Pro-Gly is underlined, H=Hydrophobic, 
P=Polar and V=Variable.  Jalview 2.4.0 and WebLogo were used to determine the consensus 
sequence and hydrophobicity was determined by ProtScale using the Kyte-Doolittle scale.   
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CHAPTER  3. Methionine Bristles in the Signal Sequence Binding Domain of 
Ffh are not Required for Function of the Escherichia coli Signal Recognition 
Particle 
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ABSTRACT 
The signal recognition particle (SRP) is a ribonucleoprotein complex important for 
targeting proteins to the cytoplasmic membrane in all living cells.  Ffh, the sole protein 
component of the SRP in E. coli, binds to signal peptides via interaction with a methionine rich 
carboxy-terminus known as the M-domain.  It was originally proposed that signal peptides bind 
the M-domain via interaction with “methionine bristles” formed by side chains of this amino acid 
located primarily on the same face of four predicted alpha helices.  Despite the appeal of this 
model, no direct test of the importance of methionine in SRP function has been made.  We used 
both phylogenetic sequence comparisons and mutagenesis, including replacing methionine 
residues with several other amino acids to test the methionine bristle hypothesis.  In addition to 
methionine, we found leucine and isolecucine are also highly abundant in the M-domain, 
actually surpassing methionine in prevalence in hyperthermophilic microorganisms.  By directly 
testing SRP function in a variety of replacement mutants we unexpectedly observed that the 
requirement for methionine does not correlate with amino acid conservation.  Substitution of all 
the methionines in the alpha M4 helix and the extreme carboxy-terminus of Ffh with leucine 
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failed to functionally replace methionine, while isoleucine only poorly replaced methionine.  As 
predicted, similar results were observed when charged or non-hydrophobic amino acids were 
used to replace methionine.  However, other amino acids, although far less conserved in 
Ffh/SRP54, functioned well as methionine replacements.  While phenylalanine, tyrosine and 
tryptophan all supported SRP function to varying degrees, valine restored SRP activity to nearly 
wild type levels.  Furthermore, valine could replace all but one highly conserved methionine 
within the entire M-domain.  This single, essential methionine residue is likely important for the 
dense packing of alpha helices within the M-domain, and does not appear to directly participate 
in signal peptide binding.  These results reveal a surprising degree of adaptability in substrate 
binding and helps explain how the SRP can target many different signal peptides and 
transmembrane domains.  Further characterization of these mutants will reveal new insights into 
how the structure of the M-domain contributes to SRP function.   
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INTRODUCTION 
 
 The signal recognition particle (SRP) is a universally conserved ribonucleoprotein 
complex important for targeting polypeptides to cellular membranes in eukaryotes, archaea and 
bacteria (10-12, 17).  The eukaryotic SRP is comprised of a 7S RNA and six proteins (39, 40), 
while in bacteria and archaea it is a simpler complex.  In E. coli, for example, the SRP includes 
the Ffh (54-homolog) protein in complex with 4.5S RNA (3, 30, 32, 33).  In all organisms, SRP 
mediated protein localization involves similar mechanisms.  As nascent polypeptides emerge 
from the ribosome, the SRP binds to hydrophobic signal sequences or transmembrane domains 
on nascent polypeptides via interaction with the Ffh (SRP54) protein.  Subsequently, the SRP-
ribosome-peptide chain complex associates with the SRP receptor (FtsY in E. coli) where the 
target protein is inserted into or across the membrane in a reaction that requires GTP hydrolysis 
by both components of the SRP and FtsY herterodimer (10-12, 17).  Consistent with its role in 
protein targeting, the structural genes encoding components of the SRP pathway, i.e., ffh, ffs and 
ftsY, are all essential for cell viability in E. coli (6, 19, 29).   
Ffh is comprised of three domains, the amino-terminal N-domain, GTP binding domain 
(G-domain) and the carboxy-terminal, methionine rich M-domain (2, 7, 13-15, 18, 25, 35).  
Biochemical and structural analysis (2, 7, 13-15, 18, 25, 35) have provided insights into how 
these domains function in membrane protein localization.   The amino terminal region of Ffh, 
comprised of the N and G domains, mediate the binding of SRP with its receptor.  Ffh and FtsY 
share sequence and structural homology in their N and G domains (24), which is consistent with 
their interaction to form a functional GTPase (21, 22, 27, 31, 36, 42).  The M-domain contains 
binding sites for 4.5S RNA and hydrophobic signal sequences (20, 34, 43).    
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 Insights as to how the SRP appears to bind its membrane protein cargo initially came 
from sequence analysis of the ffh gene cloned from E. coli (3).  Upon observing that the carboxy 
terminal domain is rich in methionines, Bernstein et al. predicted that the unique characteristics 
of this amino acid are important for binding signal sequences.  Since the side chains of 
methionines are hydrophobic, yet retain flexibility, they likely form the signal sequence binding 
region of the protein.  In this model, properly positioned R-groups protrude outward to form 
“bristles” that allow signal sequences to bind through hydrophobic interactions.  Because the 
SRP must be able to bind a variety of signal sequences, it was thought that the bristles would 
allow for adaptability of the region (3).    
 Indeed, crystal structures of the Ffh protein from multiple sources generally support the 
“methionine bristle” model (2, 7, 13-15, 18, 25, 35).  In all cases, the M-domain is composed of 
multiple α-helices that, along with a flexible loop known as the finger loop, form a hydrophobic 
binding pocket for membrane proteins that is exposed on the surface of the protein.  The binding 
region can accommodate hydrophobic transmembrane domains and signal sequences of exported 
proteins through interaction with the side chains of methionine residues, as well as other 
hydrophobic amino acids found in the carboxy-terminus of Ffh.  Figure 1A shows the structure 
of the M-domain of Thermus aquaticus (18).  As in most Ffh proteins, the M-domain consists of 
four α helices (αM1-4),  arranged such that αM1, αM2 and αM4 along with the finger loop, 
which connects αM1 and αM2, form the hydrophobic binding groove.  Structural determination 
also shows that this groove is lined with the side chains of several hydrophobic residues, 
including a preponderance of methionine.  More recently, the crystal structure of an Ffh-signal 
peptide complex was determined (15).  As predicted from previously determined structures (2, 7, 
13-15, 18, 25, 35), the crystal structure revealed the model signal peptide indeed binds in the 
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hydrophobic groove formed by αM1, αM2 and αM4 (Fig. 1B).  Furthermore, while the signal 
peptide makes significant contacts with αM4, the finger loop appears to form a “lid” over the 
hydrophobic binding groove (15).  A similar structure was predicted to be formed by the T. 
aquaticus M-domain (18), with the exception that many of the methionine residues were 
substituted with other hydrophobic amino acids including leucine, isoleucine and phenylalanine.  
The increase in thermal motion of the amino acid side chains at the higher growth temperatures 
of T. aquaticus appears to compensate for the reduced flexibility of the side chains of leucine, 
isoleucine and phenylalanine (18).    
 Despite the predicted importance of methionine residues for Ffh function, there have 
been no direct tests of the “methionine bristle” hypothesis.  To address this, we have performed a 
systematic analysis of the Ffh M-domain both by comparative analysis and by mutagenesis.  
Mutants were generated by replacing the ten methionine residues in αM4 and the extreme 
carboxy-terminal region of Ffh, representing half of the total number residues of this amino acid 
in the M-domain, with several other amino acids.  By characterizing each mutant for viability, 
growth, and SRP function we were able to identify specific amino acid substitutions that can 
functionally replace methionine, hence providing new insights into signal peptide binding by 
Ffh.   
 
MATERIALS AND METHODS 
Bacterial strains and plasmids.  The strains and plasmids used in this study are shown in Table 
1.   
Reagents.  Restriction enzymes and other enzymes used for recombinant DNA were obtained 
from New England Biolabs (Ispsich, MA) and Fermentas Life Sciences (Glen Burnie, MD).  
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PCR primers and synthetic genes were obtained from Integrated DNA Technologies (Coralville, 
IA).  Growth medium were obtained from Difco (Detroit, MI).  All antibiotics and other 
chemicals were obtained from Sigma Chemical Co. (St. Louis, MO).   
Construction of Ffh M-domain mutant alleles.  Each M-domain mutant (Table 2) was 
constructed by gene synthesis (Integrated DNA Technologies, Coralville IA).  DNA constructs 
corresponding to the region of ffh encoding the αM4 helix (Fig. 1) and the unstructured carboxy 
terminus of the protein were obtained from IDT (Coralville Iowa).  Each 126-bp construct, was 
synthesized so that all of the base triplets specifying methionine were replaced by alanine, 
cysteine, glutamate, isoleucine, leucine, phenylalanine, tryptophan, tyrosine or valine.  Each 
construct was digested with XmnI-SacI and used to replace a similar segment from pSLD-ffh10 
(Table 1).  Plasmid DNA was isolated using a Qiagen miniprep kit (Qiagen, Valencia, CA) and 
all constructs were confirmed by DNA sequencing (DNA Sequencing and Synthesis Facility at 
Iowa State University).  Two additional synthetic constructs were also designed by replacing 
every triplet encoding methionine in the entire M-domain with either valine or a combination of 
valine and methionine (Table 1).  These segments of ffh were introduced to pSLD-ffh10 using 
PvuII-SacI. 
 To construct plasmids expressing ffh under lac control, an AgeI and AatII segment was 
replaced with the corresponding region from pSLD-ffh10 and 15.  
Western blot analysis.  To facilitate detection of Ffh, DNA encoding a cMyc epitope tag was 
positioned onto the end of each ffh construct.  A construct carrying a DNA fragment encoding 
the cMyc epitope tag (EQKLISEEDL) was obtained from IDT (Coralville Iowa).  The cMyc 
epitope tag was introduced to the pSLD-ffh plasmids at the 5' of ffh using FspAI and SalI.   
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Complementation tests.  The pSLD-ffh plasmids were transformed into SLD106 (Table 1) as 
described previously (29).  Transformants were plated in duplicate on LB agar plates 
supplemented with ampicillin (Amp) (100µg/ml) and incubated at 30
o
C and 42
o
C.   Amp
R
 
transformants that grew at 42
o
C were restreaked on LB agar plus spectinomycin (Spc) 
(100µg/ml) plates and incubated at 30
o
C to test for Spc
s
, indicating loss of the temperature-
sensitive plasmid pTS-Spc-ffh
+
.  To test the ability of pLac-ffh derivative plasmids to 
complement transformants were plated in duplicate on LB agar plates supplemented with Amp 
(100µg/ml) plus isopropyl-β-D-thiogalactopyranoside (IPTG) (0.1 mM) and incubated at 30oC 
and 42
o
C.  Amp
R
 transformants were restreaked on LB plus Spc plates and incubated at 30
o
C to 
test for Spc
s
.   
Construction of F' plasmids.  Recombineering was used to construct new F' plasmids, similar 
to that described by Peterson and Phillips (29).  For this, a gene cassette encoding 
chloramphenicol resistance (Cam
R
) was first introduced to a unique XbaI restriction site at the 3' 
end of ffh on the plasmids pSLD-ffh10, pSLD-ffh14, pSLD-ffh16, pSLD-ffh17, pSLD-ffh18 and 
pSLD-ffh19.  PCR was used to amplify ffh-cam using primers ffh-lacA.S2 and ffh-lacA.AS (5'-
ATTGCACCCAACGTTACTCTTTCCGTTACGGGACACCCTGTACACGCAAGATTCCGA
ATACCGCAAG-3' and 5'-CGCCACGACGTTTGGTGGAATGTCTTTTGTGACGATACTAC 
CCGCCAGCTATGACCATGATTACGCC-3') using cycling conditions of: 2 min at 94°, 30 
cycles of (30 sec at 94°, 2 min at 55°, 1 min at 72°), 10 min at 72°.  Each PCR product was gel 
purified using the Qiagen QIAquick Gel Extraction kit (Qiagen, Valencia, CA) and was 
introduced to F'lac proA
+
B
+
 by homologous recombination at lacA using recombineering.  
Recombineering was carried out by transferring 0.05 ml of overnight cultures of CSH100 F'lac 
proA
+
B
+
 to 5 ml of fresh LB and grown at 30°C with continuous shaking until an OD600 of 0.6 
72 
 
 
was reached.  To induce the Red recombinase genes the culture was shifted to 42°C with 
continued shaking for 15 minutes.  Cultures were immediately placed in an ice water slurry and 
swirled for 5 minutes.  Cells were pelleted at 4°C and washed four times with ice cold, sterile, 
nanopure water and were subsequently resuspended in 50 l of water.  ~1 g of each PCR 
product was electroporated into CSH100 F'lac proA
+
B
+
.  Cam
R
 recombinants were selected at 
30°C on LB plus Cam (12.5 g/ml) plates. Conjugation was then used to move each of the new 
F' factors into the recipient strain SLD106 (Table 1).  The donors and recipient were patched 
together on an LB agar plate and incubated at 30
o
C for 6 hours.  Transconjugates were selected 
by streaking cells onto LB agar plates supplemented with Cam (12.5 g/ml) and Kan (30 g/ml) 
to counterselect against the donor strains.  
Growth rate measurements.  To compare growth rates of the ffh mutants expressed at different 
levels and at different temperatures, Spc
s
 transformants were restreaked on LB agar plates 
supplemented with Cam (20µg/ml), when testing pSLD-ffh mutants, or Amp (100µg/ml) plus 
IPTG (0.1 mM), when testing pLac-ffh mutants, and incubated at 26
o
C, 30
o
C, 37
o
C, and 42
o
C.   
 To compare growth of the mutants in single copy, a single colony from each of the 
SLD106 F' transformants were inoculated into 50 ml LB plus Cam (20µg/ml) and grown with 
aeration at 30
o
C, 37
o
C or 42
o
C.  Samples were removed at half hour intervals from the cultures 
for measurement of OD600.          
SRP dependent localization of FtsQ assay.  SRP dependent localization of a modified inner 
membrane protein FtsQ was detected using the biotinylation assay described previously (26, 38).  
Each SLD106 derivative mutant carrying wild-type ffh or the ffhα4MI, ffhα4MW, 
ffhα4MF, ffhα4MY and ffhα4MV alleles was transformed with plasmid pBADftsQ-V5-
PSBT (29).  Cells were grown at 37
o
C in 5 ml of LB broth supplemented with Cam (12.5 g/ml) 
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to mid-logarithmic phase and subsequently induced with 0.02% L-arabinose.  Upon reaching an 
OD600 of ~0.6, a 2 ml volume of the cells were pelleted by centrifugation at 13,000 rpm in a 
microcentrifuge. The pellets were resuspended in 100µl of nanopure water.  Subsequently, 40µl 
of the samples were mixed with 38µl of Laemmli sample buffer (Bio Rad, Hercules, CA) and 
2µl of β-mercaptoethanol, boiled for 5 min, and then recentrifuged and prepared for SDS-PAGE 
analysis using Pierce 8-16% Precise Protein Gels (Pierce, Rockford, IL).  Proteins were 
transferred to a nitrocellulose membrane and probed for FtsQ using rabbit anti-V5 antibody 
(Bethyl Inc., Montgomery, TX) and goat anti-rabbit-horseradish peroxidase conjugate (Pierce, 
Rockford, IL).  As described by Park et al. (26), biotinylated FtsQ was detected using 
streptavidin-horseradish peroxidase conjugate (Pierce, Rockford, IL).  The SuperSignal West 
Femto substrate kit (Pierce, Rockford, IL) was used for protein visualization and imaged on a 
ChemiImager 5500 (Alpha Innotech, San Leandro, CA). 
β-galactosidase assays.  The plasmid pBAD-ftsQ-lacZ (Table 1) was constructed by inserting 
lacZ (generated by PCR) into the unique KpnI site in ftsQ on pBADftsQ-V5-PSBT as to fuse 
ftsQ in frame with lacZ,  pBAD-ftsQ-lacZ was transformed into strains SLD106 containing the 
pSLD-ffh plasmids (Table 1).  Transformants were plated on LB agar plates supplemented with 
Cam (20µg/ml) plus Amp (100µg/ml) plus 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
(X-gal) (40 ug/ml) and incubated at 37
o
C and 42
o
C (in the case of mutant ffhα4MI, which only 
grows at 42
oC).  β-galactosidase assays were performed on overnight cultures grown in the 
absence of arabinose, as described by (23).   
Sequence comparisons.  SRP54/ Ffh sequences were downloaded from the NCBI database (1).   
Multiple sequence alignments and consensus sequences for 20 hyperthermophiles (16 archaea 
and 4 bacteria), 46 thermophiles (8 archaea and 38 bacteria), 11 psychrophiles (2 archaea and 9 
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bacteria) and 63 mesophiles (2 archaea and 61 bacteria) were generated using Jalview (41) and 
Weblogo (8). 
 
RESULTS 
 
Distribution of methionine in the M-domain of Ffh.   Upon determining the crystal structure 
of the Ffh M-domain from Thermus aquaticus, Keenan et al. (18) predicted that several 
conserved methionine residues are substituted in this thermophile with other hydrophobic amino 
acids with less flexible side chains.  To test this hypothesis, using much larger data sets than that 
available to Keenan et al., we selected ffh sequences from microorganims representing a range of 
optimal growth temperatures (OGT), including hyperthermophiles (OGT ≥75oC), thermophiles 
(40
o
C-75
o
C), mesophiles (25
o
C-40
o
C) and psychrophiles (10
o
C-15
o
C).  As shown in Fig 3, while 
residues with less flexible side chains (e.g. leucine, phenylalanine, isoleucine and valine) were 
indeed substituted for methionines in the M-domain of hyperthermophiles and thermophiles, 
mesophiles and psycrophiles were comprised extensively of methionines.   
 While the positions of most of the methionines were highly variable throughout the M-
domain, we observed three positions, (corresponding to residues 344, 383 and 426 of E. coli 
Ffh), were very highly conserved among all four groups of microorganisms.  Expanding the 
comparison to include all three domains of life revealed that these three conserved positions were 
nearly invariant (data not shown), with position 383, located in αM3, the SRP RNA binding 
helix, being 100% conserved.  Methionine residues corresponding to positions 344 and 426 of E. 
coli Ffh were 72% and 44% conserved in hyperthermophiles, 54% and 59% in thermophiles, 
73% and 75% in mesophiles, and 100% and 91% in psychrophiles, respectively.  These positions 
are highlighted in Fig. 1B and Fig.1D. 
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Construction of new Ffh M-domain mutants.   Of the twenty methionines in the M-domain of 
E. coli Ffh, half are contained within the αM4 helix (positions 423, 426, 427, 430) and 
unstructured “tail” at the extreme carboxy-terminus (positions 435, 438, 439, 442, 445 and 446).   
As shown in Fig. 3, although methionines are clustered in this region of the M-domain, there is 
significant variability in amino acid composition of the unstructured tail.  While methionines in 
the αM4 helix were almost exclusively substituted with hydrophobic residues, methionines found 
in the extreme carboxy-terminal tail were frequently substituted with polar and charged residues.  
To assess the importance of the 10 methionine residues for SRP function in E. coli, we replaced 
all 10 amino acids with residues containing different chemical properties.  The replacements 
included hydrophobic amino acids with non-bulky side chains (alanine, isoleucine, leucine, and 
valine); hydrophobic, with bulky side chains (phenylalanine, tryptophan, and tyrosine); a charged 
side chain (glutamate); and the other hydrophobic, sulphur containing side chain (cysteine).  As 
summarized in Table 1, we designated each of these mutant alleles as ffhα4M. 
 Initially, we expressed all mutants from a multiple copy number plasmid (Materials and 
Methods).  The ability of each mutant to function as a component of the SRP was tested by 
transforming each plasmid construct into SLD106 (Table 1).  This strain carries ffh::kan1 allele 
(26), which is complemented by wild type ffh carried on a plasmid that confers Spc
R
 and is 
temperature sensitive for replication.   As a consequence, SLD106 grows at 42
o
C only if it is 
provided with a functional copy of ffh.  As shown in Fig. 4, we observed that mutants 
ffhα4MA, ffhα4MC ffhα4ME and ffhα4ML all failed to complement ffh::kan1.  The 
remaining transformants were confirmed to be Spc
S
, indicating loss of the temperature sensitive 
plasmid.  
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To quantify the expression of the ffhα4M mutants, we modified each of the pSLD-ffh 
plasmids (Table 1) by introducing a DNA fragment encoding the cMyc epitope tag 
(EQKLISEEDL) to the 5' of ffh. Complementation tests were repeated with each cMyc 
derivative with similar results (data not shown).  Western blot analysis using antibody against the 
cMyc epitope revealed that all of the mutants expressed Ffh at levels comparable to the wild type 
protein (Fig. 5A).   
Although the ffhα4M alleles were expressed from multiple copy (ColE1-deriviative) 
number plasmids (Table 1), we reasoned that further elevating the expression of the mutants that 
failed to complement could restore their function.  To test this, we cloned ffhα4MA, 
ffhα4MC, ffhα4ME and ffhα4ML into a plasmid where their expression was under control 
of the lac promoter.  We observed that while ffhα4MA, ffhα4MC and ffhα4ME again 
yielded no colonies when transformed into SLD106 in the presence of IPTG, ffhα4ML gave 
rise to small colonies.  However, the colonies failed to form single colonies upon restreaking 
(data not shown).   
Phenotypes of M-domain mutants expressed at physiological levels.  To more accurately 
determine how well each allele functioned as a component of the SRP, we tested the ability of 
the five functional mutants to complement when expressed in single copy.  Using the strategy 
described by Peterson and Phillips (28), we constructed a series of F' plasmids and repeated the 
complementation tests after introducing wild type ffh and each of the functional ffhα4M alleles 
(ffhα4MF, ffhα4MI, ffhα4MV, ffhα4MW, and ffhα4MY) into SLD106 in single copy.  
Following conjugation with SLD106, transconjugants were selected at 42
o
C to test for 
complementation.  Although the wild type control and the five functional ffhα4M alleles were 
able to complement ffh::kan1 in SLD106 in single copy, the mutants complemented with 
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different degrees of efficiency.  Because several of the substitutions were made with amino acids 
that were more hydrophobic, with less flexible side chains than methionine, we determined if 
growth temperature could influence the results of complementation test results.  Upon 
restreaking each of the SLD106 transformants at 30
o
C, 37
o
C, and 42
o
C we noted differences in 
growth, suggesting that the products of the alleles were not functionally equivalent.  For 
example, as shown in Fig. 6A (Top row), ffhα4MI did not grow at 30oC.  To quantify 
differences in the growth rate of each mutant, strains were cultured at 30
o
C, 37
o
C and 42
o
C and 
growth rate constants were measured.  As shown in Table 2, both ffhα4MI and ffhα4MW 
grew optimally at 42
o
C, whereas the remaining mutants displayed optimal growth at 37
o
C.   
Ffh M-domain mutants affect SRP function.  To directly test the effect of the amino acid 
substitutions on SRP function we monitored the localization of FtsQ, an inner membrane protein 
whose localization is SRP dependent (37, 38).  For this, we expressed a derivative of FtsQ that 
includes the biotinylation domain of transcarboxylase from P. shermanii (PSBT).  In wild type 
cells, membrane protein targeting is so efficient that the protein fails to be biotinylated.  
However, when SRP function is compromised, FtsQ is retained in the cytoplasm and becomes 
modified by biotinylation (26, 37, 38).  For this assay we used pBADftsQ-V5-PSBT (16, 28).  As 
shown in Fig. 7A, almost no biotinylated FtsQ was detected in the wild type control strain; 
however, various amounts were detected in the mutants, the greatest being observed in mutants 
ffhα4MI, ffhα4MW and ffhα4MY.   The degree of biotinylation correlated directly with 
the growth rates of each mutant, with the greatest defects observed in mutants ffhα4MI, 
ffhα4MW and ffhα4MY (Fig. 7A lanes 3, 5 and 6).       
β-galactosidase activity of Ffh M-domain mutants.  As an independent means to test the effect 
of the functional ffhα4M mutants on SRP function, we measured β-galactosidase activity from 
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strains expressing an ftsQ-lacZ fusion encoding a hybrid protein where the signal sequence of 
ftsQ is fused to the amino terminus of lacZ.  It is well established that the product of lacZ, 
encoding a cytoplasmic enzyme, exhibits low activity when localized to the membrane (4, 37, 
38).  Consequently, β-galactosidase activity is an indirect measurement of SRP function since 
activity is detected only when the protein is poorly targeted to the membrane.  As shown in Fig. 
7B, the amount of β-galactosidase activity determined for each ffhα4M mutant correlated with 
the results of the FtsQ biotinylation assays described above (Fig. 7A).   
A truncated ffh mutant.   Given the results that substitutions of up to 10 methionine residues in 
the C-terminus of Ffh still supports function of the SRP in E. coli, we further distinguished the 
importance between residues located in the αM4 helix and those in the unstructured extreme end 
of the protein.  For this we introduced an amber nonsense mutation corresponding to position 
436 of Ffh and tested the ability of this mutant to support growth of SLD106.  The truncated ffh 
mutant was able to complement ffh::kan1 in SLD106 when expressed in multiple copy; however, 
it failed to support cell viability when expressed in single copy.  Western blotting confirmed the 
product of this allele was expressed at levels comparable to that of wild type (Fig. 5B).  
Construction of a “valine thistle” mutant.   Since substitution of valine for methionine in αM4 
resulted in nearly wild type SRP activity (Fig. 6-Top row and Fig. 7), we next determined if 
replacement of every methionine within the Ffh M-domain was likewise functional.  For this, we 
constructed the ffhMVα1-4 allele by substituting all 20 ATG triplets within the M-domain 
with GTG.  Although the product of this mutant allele was expressed at levels comparable to 
wild type, as confirmed by Western blotting (Fig. 5B), it failed to complement in SLD106 (Fig. 
6- Bottom row).  As described above, we identified 3 highly conserved methionines at positions 
344, 383 and 426 (Fig. 1D).  To determine the importance of these residues, we modified the 
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ffhMVα1-4 mutant to include these 3 highly conserved methionines (ffhVM(x3)).  In 
contrast to the ffhMVα1-4 mutant, the product of ffhVM(x3) supported growth of SLD106 
at nearly wild type levels when expressed in both multiple copy number and in single copy (Fig. 
6-Bottom row).  Further characterization of this mutant and its effect on SRP function showed 
that localization of the ftsQ-lacZ gene product is slightly reduced, as indicated by elevated β-
galactosidase activity (Fig. 7B). 
 
DISCUSSION  
 The importance of methionine residues for signal sequence binding by Ffh was first 
proposed by inspection of the predicted primary sequence of the E. coli Ffh protein (3).  
Bernstein et al. (3) proposed that the flexible, hydrophobic side chains of methionine represented 
“bristles” that formed the basis for signal peptide recognition by the SRP.  Since then, several 
Ffh/SRP54 proteins have been crystallized and confirm that the side chains of methionine and 
other hydrophobic amino acids line the signal peptide binding groove of the M-domain (Fig. 1) 
(2, 7, 13-15, 18, 25, 35).  Keenan et al. (18) further proposed that leucine and isolecuine, could 
substitute for methionine in organisms whose higher optimal growth temperatures could 
compensate for the less flexible R groups of these amino acids.   
 Since these original proposals, much larger data sets have become available for analysis.  
We used multiple sequence alignment comparisons, to measure the prevalence of methionine in 
the M-domain of Ffh/SRP from a wide range of organisms, including microorganims with 
different optimal growth temperatures.  As shown in Fig. 2, we found that the prevalence of 
methionine in the M-domain largely correlates with the optimal growth temperature of its host 
organism.  While methionine comprises 11% of the amino acids in the M-domain from 
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mesophiles, including E. coli, the percentage increases to 13% in psycrophiles whose optimal 
growth temperature is <20
o
C.  As originally proposed by Keenan et al. (18) leucine and 
isoleucine replaced methionine in thermophiles (OGT range is 40
o
C-75
o
C), and even to a great 
extent in hyperthermophiles (OGT ≥75oC).   
 While sequence comparisons suggested the importance of methionine to SRP function, 
particularly in mesophiles and psychrophiles, we directly tested this by constructing several M-
domain variants and determining their ability to function in E. coli.  We observed that of the 20 
methionine residues in the E. coli Ffh M-domain, 50% were clustered in αM4 and the carboxy-
terminal end of the protein (Fig. 1).  Phylogenetic sequence analysis of the four groups of 
microorganisms revealed that methionines occur more frequently in αM4 with increased residue 
variability in the carboxy-terminus (Fig. 3).  Recent structural analysis of SRP and a signal 
peptide (15) indicates that αM4 contributes a significant “platform” to the signal peptide binding 
groove (Fig. 1).  Consequently, we simultaneously replaced all of the methionines in αM4 (4 
residues) and the unstructured carboxy-terminal tail (6 residues) with amino acids differing in 
hydrophobicity, side chain flexibility and charge (Table 2).  Surprisingly, the requirement for 
methionine is not as stringent as suggested from phylogenetic comparisons.  The ffhα4ML 
mutant was not viable, even when overexpressed (Fig. 4-Bottom row), and ffhα4MI functioned 
well only when expression was elevated (Fig. 4-Top row).  In contrast, the ffhα4MV mutant 
supported growth near wild type levels when expressed in single and multiple copy (Figs. 4 and 
6).  As summarized in Fig. 4, other hydrophobic amino acids were also capable of replacing 
methionine. As anticipated, replacement of methionine with a charged amino acid (glutamate) 
failed to function, as did replacement with alanine, whose R-group hydrophobicity is 
significantly lower than methionine or valine.  In addition, replacement with cysteine, the other 
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sulphur containing amino acid, failed to support SRP function (Fig. 4-Bottom row).  None of the 
methionine replacements significantly altered protein levels (Fig. 5).    
 To more rigorously assess the ability of the amino acid replacements to support SRP 
function, we constructed a series of F  factors to place the ffhα4M alleles in single copy so that 
complementation tests could be performed at physiological levels of expression.  While several 
of the mutants complemented in SLD106 at near wild type levels when expressed from a 
multiple copy-number plasmid (Fig. 4), use of F  factors revealed additional differences between 
the mutants.  For example, while ffhα4MV, ffhα4MF, ffhα4MY and ffhα4MW and 
ffhα4MI were all able to complement in single copy (Fig. 6-Top row), the isoleucine and 
tryptophan replacements complemented only at 42
o
C (Fig. 6-Top row and Table 2). This result is 
consistent with the observation that amino acids with less flexibility are substituted for 
methionine residues in the M-domain in organisms that grow at higher temperatures.  
Conversely, the tyrosine replacement mutant complemented best at 30
o
C (Fig. 6-Top row and 
Table 2).  Each of the mutants were also shown to have varying effects on SRP-dependent 
protein targeting (Fig. 7A), as measured by monitoring targeting of the SRP-dependent 
cytoplasmic membrane protein FtsQ by biotinylation and by measuring β-galactosidase activity 
of the product of an ftsQ-lacZ gene fusion (Fig. 7).  These differences correlated with the growth 
rate of each mutant when the ffhα4M alleles were expressed in single copy.  Collectively, the 
results reveal that SRP function in each of the mutants compared to wild type is ordered as 
follows:  ffh
+
 (wild type) >  ffhα4MV >  ffhα4MF > ffhα4MY > ffhα4MW > ffhα4MI 
> ffhα4ML > ffhα4MA, ffhα4ME, ffhα4MC. 
 Because the extreme carboxy-terminus was shown to be highly variable among all of the 
microorganisms used in this study, we also determined that this region of Ffh was important for 
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SRP function.  A mutant deleted for the carboxy-terminal tail was viable only when expressed 
from a muliple copy number plasmid (data not shown).   
 Since ffhα4MV grew near wild type levels (Fig. 6-Top row and Fig. 7), we further 
tested its ability to fully replace methionine by constructing a mutant allele where all 20 of the 
methionine residues in the M-domain were replaced with valine (Fig. 1D).  This “valine thistle” 
mutant failed to support cell viability in E. coli, however.  Multiple sequence alignments of the 
M-domain revealed three amino acids, corresponding to positions 344, 383 and 426 of E. coli 
Ffh, were highly conserved.  Interestingly, position 383, found in helix αM3 was invariant in all 
four groups.  We found that restoring methionine at these three positions in ffhMVα1-4, 
yielding allele ffhVM(x3), expressed a protein that was able to complement ffh::kan1 in 
SLD106 when expressed in both multiple and single copy (Fig. 6-Bottom row).  
 The results presented were not anticipated based upon phylogenetic sequence analysis. 
Although valine is structurally similar to leucine and isoleucine, its R group is shorter and 
comparatively less hydrophobic, it possesses sufficient properties to support SRP function at 
nearly wild type levels.  While some proteins may be more dependent upon methionine bristles 
for efficient membrane localization, polypeptides essential for bacterial growth must be less 
dependent for efficient targeting.  While methionine side chains may possess the balance of side 
chain length and hydrophobicity for efficient signal peptide recognition, as suggested by its high 
degree of conservation, SRP can function with several hydrophobic R-groups in the M-domain.  
The failure of leucine and isoleucine, at lower growth temperatures, to replace methionine may 
reflect the loss of helical structure in the M-domain and may not be directly related to the 
inability of these amino acids to bind signal peptides.  Biochemical experiments will be required 
to test this.  Also, it is possible that of the three most highly conserved methionines in the M-
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domain (Fig. 1D), not all of them may be required for Ffh function.  Of these, methionine-383 
does not appear to contact signal peptides (Fig. 1A) and may be important for maintaining the 
structure of the highly packed helical region of the M-domain.   
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Fig. 1.  Structures of the Ffh M-domain.  (A)  Structure of the M-domain of Ffh from Thermus 
aquaticus (Protein Data Bank 2Ffh) showing the signal sequence binding groove formed by αM1 
(blue), αM2 (green), αM4 (red) and the finger loop (magenta).  Helix αM3 (orange) has been 
shown to bind the SRP RNA.  (B)  Modified structure of the Sulfolobus solfataricus SRP54–
signal peptide fusion protein (Protein Data Bank 3KL4).  The three highly conserved methionine 
residues revealed by sequence analysis are shown in white and the signal sequence in shown in 
yellow.  (C) Mutant ffhMVα1-4 modeled using the structure of the M-domain of Ffh from T. 
aquaticus (Protein Data Bank 2Ffh) showing methionine residues that were substituted with 
valine (yellow).   (D) Mutant ffhVM(x3) modeled using the structure of the M-domain of Ffh 
from T. aquaticus (Protein Data Bank 2Ffh).  The three highly conserved methionine residues are 
shown in red and valine residues are shown in yellow.    
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Fig. 2.  Representatives of amino acids found in the M-domain of Ffh.  The occurrence, 
shown as percentages, of hydrophobic residues located in the entire M domain of Ffh from 
hyperthermophiles, thermophiles, mesophiles and psychrophiles.     
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Fig. 3.  Comparison of Ffh M-domain sequences from bacteria and archaea representing 
varying optimal growth temperatures.  Four methionine residues in the αM4 domain 
(positions 423, 426, 427, 430) as well as 6 additional residues at positions 435, 438, 439, 442, 
445 and 446 at the extreme C-terminus from Ffh in E. coli were compared to sequences from 
four groups based upon OGT and using multiple sequence alignments.  The percentage of 
occurrence of each amino acid listed in the legend is represented.  Methionine residues among all 
four groups are found to occur frequently in positions 1, 2, 3 and 4 (found in αM4).        
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Fig. 4.  Growth of ffhαM4 mutants.  Strain SLD106 was transformed with plasmids expressing 
ffhα4MF, ffhα4MW, ffhα4MI, ffhα4MY, ffhα4MV and the positive control (ffh+), as 
shown, in multiple copy numbers and incubated at 42°C (Top Row). Mutant alleles ffhα4ML, 
ffhα4MA, ffhα4MC, and ffhα4ME failed to complement (Bottom Row).     
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Fig. 5. Detection of products of mutant ffh alleles.  Western blot analysis was used to 
detect the expression of  wild type ffh and ffhα4M mutants (A) ffh+ (WT),  ffhα4MV (V), 
ffhα4MF (F), ffhα4MY (Y), ffhα4MW (W), ffhα4MI (I), ffhα4ML (L), ffhα4MA 
(A), ffhα4MC (C) and ffhα4ME  (E) and (B) ffh+ (WT), ffhMVα1-4 (Vα1-4), 
ffhVM(x3) (V-Mx3) and ffhM∆C (M∆C) using antibody against the cMyc epitope. 
Differences in protein size in (A) and (B) are a result of running the protein samples on different 
types of protein gels.  The same molecular weight marker was used in (A) and (B). 
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Fig. 6.  Phenotypes of ffh M-domain mutants.  (Top Row) Mutants representing αM4-C 
terminus mutants in single copy. Colonies grown and restreaked at 30
o
C, 37
o
C and 42
o
C showing 
positive control WT (ffh
+α4), F (ffhα4MF), W (ffhα4MW), I (ffhα4MI), Y (ffhα4MY) 
and V (ffhα4MV).  (Bottom Row) Mutant VM(x3) (ffhVM(x3)) expressed in single copy. 
Colonies grown and restreaked at 30
o
C, 37
o
C and 42
o
C showing positive control (ffh
+α4) and 
ffhVM(x3).    
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Fig 7. SRP activity of ffh mutants.  (A) Levels of biotinylation of FtsQ, WT (wild type), V 
(ffhα4MV), Y (ffhα4MY), F (ffhα4MF), W (ffhα4MW), I (ffhα4MI).  Wild type and 
mutants were tested for the amount of biotinylated inner membrane protein FtsQ.  (Top panel) 
Biotinylated FtsQ detected using streptavidin-horseradish peroxidase conjugate.  (Bottom panel) 
FtsQ detected by Western Blot analysis using Rabbit-anti-V5 primary antibody.  (B) β-
galactosidase activity of the ffh M domain mutants was measured and reported in Miller units.   
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Table 1: Strains and plasmids used in this study  
Strain of plasmid Relevant genotype or description Source or 
Reference 
E. coli strain   
 NEB5α  fhuA2Δ(argF-lacZ)U169 phoA glnV44 80 
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
(general cloning host) 
New 
England 
Biolabs 
 MC4100 F
-
 araD139, Δ(argF-lac)U169, rspL150, relA1, 
flbB5301, fruA25, deoC1, ptsF25 e14- 
Lab 
collection 
 WAM100 MC4100, ara
+
 (29) 
 WAM121 WAM100, attB:: ParaBAD-ffh
+
, ffh::kan1  
(source of ffh::kan1 allele) 
(9) 
 SLD106 WAM100, ffh::kan1, pffhTS-Spc (Spc
R
) (Tet
R
) This study 
 ECF529 Δ araBAD, ΔrhaBAD, ΔaraFGH, ΔaraE,  
rrnBPI(CTC-AGA)-lacYA177C 
(5) 
 XLU102 ECF529, bla:: Δkan Lab 
collection 
 SLD108 XLU102, ffh::kan1, pffhTS-Spc This study 
 CSH100 F' lac proA
+
B
+
 (lacI
q
 lacPL8)/araD (gpt-lac)5 
(source of F' lac) 
(23) 
Plasmid   
 pffhTS-Spc 
 
pSC101ts, ffh
+
spc (Spc
r
) 
 
Lab 
collection 
 pSLD-ffh10 ffh
+
, bla (Amp
R
), ColE1 This study 
 pSLD-ffh11 ffhα4MA, AmpR, ColE1 This study 
 pSLD-ffh12 ffhα4MC, AmpR, ColE1 This study 
 pSLD-ffh13 ffhα4ME, AmpR, ColE1 This study 
 pSLD-ffh14 ffhα4MI, AmpR, ColE1 This study 
 pSLD-ffh15 ffhα4ML, AmpR, ColE1 This study 
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Table 1: (continued) 
Strain of plasmid Relevant genotype or description Source or 
Reference 
Plasmid   
 
 
pSLD-ffh16 ffhα4MF, AmpR, ColE1 This study 
 pSLD-ffh17 ffhα4MW, AmpR, ColE1 This study 
 pSLD-ffh18 ffhα4MY, AmpR, ColE1 This study 
 pSLD-ffh19 ffhα4MV, AmpR, ColE1 This study 
 pSLD-ffh20 ffhM∆C(amber mutation at position 436), AmpR, 
ColE1 
This study 
 pSLD-ffh21 ffhMVα1-4, AmpR, ColE1 This study 
 pSLD-ffh22 ffhVM(x3)( positions 344, 383 and 426), AmpR, 
ColE1 
This study 
 pLac-ffh Vector for expression of ffh under Plac control,Amp
R
 Lab 
collection 
 pBADftsQ-V5-PSBT  (28) 
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Table 2: Ffh α4M domain mutants 
ffh Allele 
Designation 
Amino Acid Sequence GRC 
30
o
C 
GRC 
37
o
C 
GRC 
42
o
C 
ffh
+α4 DDMQRMMKKMKKGGMAKMMRSMKGMMPPGFPGR 0.75 0.97 1.04 
ffhα4MA DDAQRAAKKAKKGGAAKAARSAKGAAPPGFPGR --- --- --- 
ffhα4MC DDCQRCCKKCKKGGCAKCCRSCKGCCPPGFPGR --- --- --- 
ffhα4ME DDEQREEKKEKKGGEAKEERSEKGEEPPGFPGR --- --- --- 
ffhα4MI DDIQRIIKKIKKGGIAKIIRSIKGIIPPGFPGR --- --- 0.66 
ffhα4ML DDLQRLLKKLKKGGLAKLLRSLKGLLPPGFPGR --- --- --- 
ffhα4MF DDFQRFFKKFKKGGFAKFFRSFKGFFPPGFPGR 0.71 0.98 1.04 
ffhα4MY DDYQRYYKKYKKGGYAKYYRSYKGYYPPGFPGR 0.73 0.96 0.42 
ffhα4MW DDWQRWWKKWKKGGWAKWWRSWKGWWPPGFPGR 0.34 0.92 1.00 
ffhα4MV DDVQRVVKKVKKGGVAKVVRSVKGVVPPGFPGR 0.73 0.97 0.96 
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CHAPTER 4. Introduction  
 In the mid 1970’s two independent methods of DNA sequencing were introduced, 
including the Sanger sequencing method, named after its developer Frederick Sanger (16, 17), 
and the chemical sequencing method developed by Maxam and Gilbert (13).  These technologies 
have had a major impact on biological research ever since.   In particular, Sanger sequencing 
became the prominent method for DNA sequence production for over 30 years, including 
sequencing of the human genome.  
 In the past five years new sequencing technologies, referred to as “next-generation 
sequencing”, have emerged and are revolutionizing biological research.  Several next generation 
sequencing platforms are commercially available including Roche/454 Genome Sequencer (9), 
Illumina/Solexa Genome Analyzer II (4, 22), Applied Biosystems SOLiD System (20).  These 
massively parallel sequencing platforms allow for rapid and cost effective generation of 
sequencing data.  Owing to the significant reduction in cost, next generation sequencing has 
provided a way for individual laboratories to carry out projects to address questions on a genome 
scale, including metagenomics, ancient DNA research, transcriptome analysis, and mapping of 
DNA-protein interactions, that previously could only be pursued by genomic centers (7, 8, 18, 
19).  
 Next generation sequencing technology has had a significant impact on bacterial 
genomics.  Several bacterial genome sequencing projects of multiple isolates of the same species 
have revealed extensive intraspecies genotypic heterogeneity (1, 5, 6, 21), which has been noted 
to have the potential to impact vaccine development and discovery of novel antimicrobials (14). 
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Despite the value of using next generation sequencing technology, the amount of genome 
sequence data and the rate of data generation presents bioinformatic challenges such as 
developing tools to organize, store, manage and analyze annotated sequencing data.  In the past 
few years, several tools have been developed to address this need including Integrated Microbial 
Genomes (IMG) system (10, 12), Integrated Microbial Genomes-Expert Review (IMG ER) 
system (11), the Microbial Genome Database (MBGD) (23, 24), the Comprehensive Microbial 
Resource (CMR) (15), and the EDGAR software (2), just to name a few.     
Although the previously mentioned software tools offer sophisticated sequence data 
analysis functionalities, they require researchers to develop a working knowledge of the software 
functionalities or to have access to the computational support needed to utilize the software.  
However, due to the increase in availability and use of next-generation sequencing technologies 
in academic, industrial and government settings computational support for individual labs may 
not be readily available.  To address some of these limitations with currently available 
computational tools, we developed the Draft Genome Evaluation Tool (DraGnET).  The 
following chapter details the development and use of the DraGnET software (3) for storage, 
management and preliminary comparative analysis of bacterial genome sequences.   
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ABSTRACT 
Background 
New “next generation” DNA sequencing technologies offer individual researchers the ability to 
rapidly generate large amounts of genome sequence data at dramatically reduced costs.   As a 
result, a need has arisen for new software tools for storage, management and analysis of genome 
sequence data.   Although bioinformatic tools are available for the analysis and management of 
genome sequences, limitations still remain.  For example, restrictions on the submission of data 
and use of these tools may be imposed, thereby making them unsuitable for sequencing projects 
that need to remain in-house or proprietary during their initial stages.  Furthermore, the 
availability and use of next generation sequencing in industrial, governmental and academic 
102 
 
 
environments requires biologists to have access to computational support for the curation and 
analysis of the data generated; however, this type of support is not always immediately available.   
Results 
To address these limitations, we have developed DraGnET (Draft Genome Evaluation Tool).  
DraGnET is an open source web application which allows researchers, with no experience in 
programming and database management, to setup their own in-house projects for storing, 
retrieving, organizing and managing annotated draft and complete genome sequence data.  The 
software provides a web interface for the use of BLAST, allowing users to perform preliminary 
comparative analysis among multiple genomes.  We demonstrate the utility of DraGnET for 
performing comparative genomics on closely related bacterial strains.  Furthermore, DraGnET 
can be further developed to incorporate additional tools for more sophisticated analyses. 
Conclusions  
DraGnET is designed for use either by individual researchers or as a collaborative tool available 
through Internet (or Intranet) deployment.  For genome projects that require genome sequencing 
data to initially remain proprietary, DraGnET provides the means for researchers to keep their 
data in-house for analysis using local programs or until it is made publicly available, at which 
point it may be uploaded to additional analysis software applications.  The DraGnET home page 
is available at http://www.dragnet.cvm.iastate.edu and includes example files for examining 
the functionalities, a link for downloading the DraGnET setup package and a link to the 
DraGnET source code hosted with full documentation on SourceForge.   
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BACKGROUND 
 DNA sequencing technology using chain-terminating dideoxy nucleoside triphosphates, 
first developed by Frederick Sanger [1, 2], has remained the mainstay of genome sequencing 
efforts for more than thirty years.  However, recently developed, new massively parallel DNA 
sequencing platforms are now extensively used to generate sequence data at a fraction of the cost 
and labor required by Sanger technology.  Three “next generation” sequencing systems that are 
currently commercially available include the Roche/454 Genome Sequencer [3], Illumina/Solexa 
Genome Analyzer II [4, 5] and Applied Biosystems SOLiD System [6].  In addition, commercial 
release of two additional platforms, including the Helicos Heliscope and the Pacific Biosmart 
SMRT, are planned for 2010 [7]. 
Collectively, these systems, with their high depth of coverage and relatively low costs, 
have allowed individual researchers to initiate genome sequencing projects that were previously 
available to only large genome centers [8-10].  The enhanced sequencing capability afforded by 
next-generation sequencing has had an especially significant impact on bacterial genomics.  By 
facilitating genome sequencing of multiple isolates of the same bacterial species, several 
examples of extensive intraspecies genotypic heterogeneity have been revealed, leading to a 
revision of many long-standing views of microbial speciation [11-14].  One of the first such 
studies revealed significant genetic variability among eight different strains of Streptococcus 
agalactiae, group B Streptococcus (GBS) [14].  After performing cross strain comparisons 
Tettelin et al. found a considerable number of genes not shared among the strains.   Their 
discovery led to the proposal of the bacterial “pan-genome”, defined as the global gene repertoire 
of a bacterial species comprised of the core genome (the set of genes shared by all the strains of 
the same bacterial species), the dispensable genome (the set of genes present in some but not all 
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of the strains) and the strain specific genes (the set of genes found only in a single strain) [14].  
Genome heterogeneity has also been noted for species of Helicobacter pylori, Staphylococcus 
aureus, and Escherichia coli [13, 15, 16].  As noted by Muzzi et al., comparative genomics of 
bacterial species has important implications for vaccine development and discovery of novel 
antimicrobials [17].  Other novel applications for next generation sequencing technologies have 
also been developed, including bacterial metagenomics [18-20], and transcriptome mapping [21-
24]. 
Despite the potential for new insights into bacterial diversity and function, important 
challenges continue to include the organization, management and analysis of genome sequencing 
data.  To address the need for tools for querying, analyzing and comparing multiple genomes of 
related species, several databases and software tools have been developed [25], including the 
Integrated Microbial Genomes (IMG) system [26, 27], Integrated Microbial Genomes-Expert 
Review (IMG ER) system [28], GenColors [29, 30], the Microbial Genome Database (MBGD) 
[31, 32], the Comprehensive Microbial Resource (CMR) [33] and the EDGAR software [34].       
The IMG system contains complete and draft microbial genome sequence data generated 
by the Joint Genomes Institute (JGI) as well as other publicly available genome data not limited 
to microorganisms.  Tools provided through IMG allow users to query, view and perform 
comparative analysis of genomes, genes and functions.  Recently, a new version of IMG called 
IMG ER has been added to the IMG system.  Tools available through IMG ER allow users to 
analyze and curate annotated microbial genome data whether it is unpublished or published.  
Although IMG ER allows users to upload their genome sequencing data for curation and 
analysis, it is not available for download and in-house use.  The GenColors software allows users 
to browse, analyze and compare genome information from complete and ongoing genome 
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projects related to prokaryotic or eukaryotic genomes.  Additionally, GenColors may be used for 
the purpose of annotation in the case of incomplete projects.  The CMR software contains 
sequence and annotation data for all of the current publicly available completed microbial 
genomes and provides a variety of comparison tools for the analysis of the multiple genomes 
including cross-genome analysis capabilities. Currently, however, there is no functionality that 
allows users to submit genome data for use with CMR.  Similar to CMR, MBGD provides users 
with several tools for the comparison and analysis of complete bacterial genomes.  Unlike CMR, 
MBGD contains a newly added feature called MyMBGD that allows users to add their own 
genome data to MBGD.  The EDGAR software has recently been released and includes 
comparative analysis tools for the comparison of multiple strains of a given species.  EDGAR 
offers similar capabilities to those found in CMR and MBGD, in addition to features such as 
phylogenetic analyses and visualization capabilities including Venn diagrams and synteny plots.     
While the aforementioned systems include data management and analysis functionalities 
there are limitations.  For example, genome projects that include proprietary data may be 
restricted in the submission of the data to third party software.  Many of the current data 
management software tools are not available for download and in-house use, a requirement when 
access to next generation sequencing instruments can outstrip the availability of experienced 
bioinformaticians to assist with data management and analysis.   
In addition to the already mentioned software applications, there are other tools that are 
designed for genome annotation or re-annotation of unpublished or published genomes [25, 35, 
36].  Several of these tools provide data curation capabilities for the purpose of correcting 
annotation errors and improving annotated data but are restricted to use with the annotated data 
generated through specified software packages.  Additionally, as with many software 
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applications, they require the researcher to develop a working knowledge of the analysis 
capabilities of the software as well as provide “expert” curation of the data.  With the increased 
use of next-generation sequencing in academic, industrial and government settings, however, 
biologists do not always have immediate access to computational support needed to easily 
manage the data and to initiate comparative analysis.   
  To overcome some of these limitations, DraGnET was developed specifically to provide 
biologists with their own web based tool that is both convenient and easy to use.  DraGnET 
allows researchers to independently store, retrieve and curate their own data generated from any 
annotation engine and to perform genome comparisons during the beginning phase of a 
sequencing project.  Additionally, publicly available genome data can be stored for the purpose 
of comparing draft genome data with reference genomes.  DraGnET includes provisions for data 
access, searching, and modification as well as access to basic local alignment search tool 
(BLAST) functionalities [37] for amino acid sequence similarity searches and cross strain 
comparisons.  As a consequence, DraGnET allows investigators to immediately begin testing of 
biologically relevant hypotheses without having to devote time to learning sophisticated analysis 
programs or to depend on computational support from designated personnel.  Additionally, the 
DraGnET source code has been made available, allowing researchers to further customize and 
develop the software to meet the needs of specific sequencing projects. 
To demonstrate the utility of DraGnET, we have successfully established a DraGnET 
project, deployed for Internet access, and performed preliminary cross strain comparisons to 
identify potential vaccine targets against the animal pathogen Haemophilus parasuis.  Microbial 
genome sequencing has proven to be a powerful approach to identify new, protective vaccines 
via reverse vaccinology, i.e., discovery of vaccine targets by scanning sequence data for potential 
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surface-exposed antigens [38].   Moreover, broadly protective antigens may be identified by 
comparison of genomes from multiple strains of a single species [17, 39, 40].  Reverse 
vaccinology has led to the development of new vaccines for several human and animal pathogens 
where previously vaccines were not available [41-44].  DraGnET enables facile preliminary 
comparisons of multiple draft or complete genome sequences of any number of organisms, 
including identification of protein encoding genes shared by multiple strains, making DraGnET a 
useful bioinformatic tool. 
 
IMPLEMENTATION 
 The DraGnET web application was developed in Java [see Additional file 1].  DraGnET 
provides user interfaces for storing information related to strains and their associated annotated 
gene set in a database.  Gene and strain information are stored as objects defined by two Java 
classes, Gene and Strain (Figure1).  The Gene class stores nine gene attributes most of which can 
be obtained from gene annotation data.  The choice of gene attributes was based upon gene 
information available in public sequence databases such as GenBank and includes additional 
attributes relevant for vaccine target identification.  The Strain class contains information such as 
the strain name and description.  Two additional Java classes, Logininformation class and the 
Blastdbupdate class are used to define objects related to administrator/curator user information 
and the date of the last modification made to the data, respectively (Figure 1).  Hibernate 
(version 3.1 core and advanced libraries) is used to map the Java objects, representing the Gene, 
Strain, Logininformation and Blastdbupdate classes, to relational tables in a MySQL (version 
5.0) database.  By using Hibernate in the software architecture, DraGnET works with an object 
database supported by Hibernate.  The servlet engine used to support the web interface is 
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Apache-Tomcat version 6. The web application uses Struts (version 1.2) to implement the 
Model-View-Controller (MVC) architecture.  The MVC architecture provides a way to separate 
the web interface (view) from the business logic (model) making it easier to implement and 
modify either component independent of the other.  The web interface (view) is implemented 
through Java Server Pages (JSP).  BLAST functionalities are provided by stand-alone executable 
BLAST software connected to the business logic and web pages are provided for users to interact 
with BLAST.  The BLAST program is configured to run the blastp (protein blast) algorithm and 
applies the blastall program available from NCBI [45].  The general layout for the architecture of 
the DraGnET software is provided in Figure 2.  The web application was built using MyEclipse 
version 6.0 and has been successfully tested on Microsoft Windows 2003 and Windows XP 
operating systems.   
 
 DraGnET project setup 
A DraGnET project can be installed on a personal computer or it can be setup for Internet (or 
Intranet) deployment making it a tool that is available for collaborative projects.  The initial 
setup of a DraGnET project requires installation of Java (version 1.6), MySQL (version 5.0) 
including the MySQL 5.0 GUI Tools, Apache Tomcat 6, and Blast 2.2.18.  Executable files for 
installing all of the aforementioned software are provided in a comprehensive setup package 
provided through the “DraGnET Application Setup Package” link located on the application’s 
home page (Figure 3).  After installing the required software packages the database structure 
used by Hibernate to map the Java objects to relational tables in the MySQL database is 
automatically generated by the MySQL 5.0 GUI Tool and a file included in the setup package 
[see Additional file 2].  This automated process alleviates the requirement of the user to have the 
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knowledge necessary for setting up the database schema used to store the genome data.  After the 
DraGnET project is set up and genome sequence data has been uploaded into the database, local 
BLAST databases for each genome need to be formatted for use with the BLAST functionalities 
provided with the application.  Information on all of these steps, as well as additional usage 
information, is available in the DraGnET_setup.doc provided in the setup package.   
RESULTS 
 DraGnET is an open source web application designed to provide researchers with a tool 
for storing their own unpublished annotated draft and complete genome data from multiple 
strains of a species in a database; allowing gene and strain information to be available for 
retrieving, searching, modifying and downloading.  The application also provides a web interface 
for the use of BLAST, allowing for protein sequence similarity searches and cross strain 
comparisons of strains stored in the database.  In addition, DraGnET provides a link for the 
automatic generation of FASTA files for each genome stored in the database.  The files are 
available for download and can be used with other software and tools for further analysis.  The 
details of the functionalities of DraGnET are provided in the following section. 
Data Management  
DraGnET is set up to allow any user to search, view and compare genome sequence data stored 
in the database; however, only curators may insert and modify the data by signing in to the 
application.  This was designed to prevent inconsistencies in the data and to protect the 
application when it is being accessed by multiple users from different locations.   
Data insertion  
Two web pages are provided for the insertion of strain and gene information.  The data entry 
tables for these pages are shown in Figure 4.  In the first table the curator enters the strain 
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information (Figure 4A) and in the second table the curator is directed to upload a file containing 
gene information for genes contained in the strain (Figure 4B). The application accepts a 
semicolon-separated plain text file, containing values for the nine gene attributes defined in the 
Gene class, for batch insertion of gene information into the database. The software then stores 
the data in the database allowing for subsequent retrievals and updates to be performed. 
Data modification 
The DraGnET application provides web pages for assigned curators to modify genome data as 
well as administrator/curator user information.  As shown in Figure 5, modifications that can be 
made to gene and strain data include adding, deleting and updating gene or strain information.  
The addition and deletion of single or multiple genes to strain(s) already stored in the database 
follows the same procedure as the addition of a strain and its associated gene set.  To delete a 
single strain the user selects the strain to be deleted and once submitted, the strain information 
and all of the genes not associated with any other strain are deleted.  An important part of data 
management is the ability to update or modify the information stored in the database, as is the 
case for draft genome sequences as progress is made toward gap closure and genome 
completion.  To update gene information, the curator enters the gene Id of the gene to be updated 
(Figure 6A).  Subsequently, the gene attributes that need to be modified are selected (Figure 6B).  
Once the selections are submitted the gene information currently stored in the database is 
displayed as "old" information and the “new” information may be entered (Figure 6C).  A similar 
procedure is provided for updating strain information. 
Formatting BLAST database files  
BLAST functionalities for sequence similarity searches and cross strain comparisons are 
provided through DraGnET web-interfaces.  To use these functionalities, BLAST database files 
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for each strain stored in the database must be created through command line arguments.  The 
command used to format BLAST database files is the similar for each strain stored in the 
database, having to change only the FASTA file used for BLAST database file generation.  
Details of this process are included in the DraGnET setup package.  Once the BLAST databases 
are created, all BLAST functionalities offered with DraGnET are available for use.   
 
Data Exploration 
The following functionalities are implemented through the web interface and are available for all 
users. 
Quick and Advanced Search 
The “Quick Search” option provides users with four different search options for retrieving gene 
and strain information stored in the database.  Searches can be performed by selecting and 
entering a gene Id, gene name, protein sequence, or strain Id (Figure 7A-B).  When a search is 
performed using a gene Id, gene name or protein sequence the results are displayed in a table 
containing information for the chosen gene, including the strain that contains the gene (Figure 
7C).  Searches based upon a strain Id provide the user with strain information as well as the 
option to download a text file containing gene information for all of the genes contained in the 
chosen strain.  The “Advanced Search” option allows users to search for gene information using 
more stringent parameters.  Users can specify single or multiple gene attributes to use in the 
advanced search (Figure 8A).  Once the attribute(s) are chosen, the user enters search criteria for 
each attribute chosen and selects the strain(s) they want to search (Figure 8B).  If more than one 
strain is chosen, then the program searches for genes having the same gene identifier and chosen 
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attributes in common with the set of strains.  Search results are written to a text file that can be 
opened for immediate viewing or saved for future inspection.   
BLAST Search 
“BLAST Search” provides users with an interface for using the protein BLAST (blastp) program 
for comparing protein sequences against protein sequence BLAST databases.  Each strain stored 
in the database is used to format BLAST protein databases during the initial setup of a DraGnET 
project.  Subsequently, the strains appear on the BLAST Search page listed under “Search 
Databases Containing Strains” where users have the option to select single or multiple strain 
databases to search against (Figure 9A). All parameters are set to NCBI defined default values; 
however users have the option to refine their search by changing the expectation value (E-value).  
Users can then input their FASTA formatted query sequence by pasting it into the query box.  
The output generated will include the input query sequence, the user chosen BLAST database(s) 
and a list of alignments between the input query sequence and the database hits.  The output file 
is available for immediate viewing and downloading (Figure 9B).    
Batch BLAST Search 
“Batch BLAST Search” is an extension of “BLAST Search” that allows text files containing 
multiple FASTA formatted protein sequences (including entire strains) to be uploaded for 
comparison against a single strain BLAST database (Figure 10).  Similar to “BLAST Search”, 
the results are written to a text file available for viewing and downloading.   
Batch BLAST Dissimilarity Search 
“Batch BLAST Dissimilarity Search” takes as input the results of “Batch BLAST Search” and 
extracts the gene identifiers associated with protein sequences that produced a “no hits found” 
result.  The resulting set of genes identifiers represents genes that have no protein sequence 
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homology to any sequences found in the selected search database.  Results are written to a text 
file. 
Generate FASTA Files 
The “Generate FASTA Files” option automatically generates FASTA files for each strain stored 
in the database.  When users click on the “Generate FASTA Files” button a set of files in 
FASTA format, one for each strain, will be available to download. Subsequently, the files can be 
used with other publicly available comparative analysis software tools or they can be saved as 
text files for use with “Batch BLAST Search”.  
 
Case study: Haemophilus parasuis genome data                                           
 To demonstrate the functionalities of DraGnET we used the web application to store 
genomic data from three strains of Haemophilus parasuis, two draft genomes (strains 29755 and 
12939) and a complete reference genome (strain SH0165) [46], and to perform preliminary cross 
strain comparisons to identify protein products common to each strain.  H. parasuis is a bacterial 
pathogen that causes severe respiratory disease in swine and vaccines effective against multiple 
isolates are lacking [47].   Since outer membrane proteins, including lipoproteins, that are shared 
among the H. parasuis strains represent potential broadly protective antigens, identifying 
common genes is a first step toward vaccine development.  Draft genome sequence data for 
strains 29755 and 12939 were generated using the Illumina/Solexa Genome Analyzer II platform 
(G. Phillips, D. Dyer, and K. Register, unpublished data).  The genomes were assembled using 
SH0165 as a reference genome using NextGene software (State College, PA). Annotation was 
performed through the Institute for Genome Sciences (IGS) Annotation Engine offered by the 
University of Maryland, School of Medicine.                                                                                                          
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 Initially, annotated genome sequence data representing the three strains were formatted 
for use with DraGnET by conversion to semicolon-separated files.  Subsequently, information 
for each strain was entered and the corresponding file was uploaded and populated in the 
database using the application’s web interface (Figure 4).  Once in the database, the annotated 
data was available for searching and modifying.  As shown in Figure 7, “Quick Search” was used 
to search for information related to the gene identifier “hph_875”; which returned a table with 
the annotated gene information.  Data modification is an important functionality provided 
through DraGnET, especially in the case of draft genome data.  To demonstrate this capability, 
gene information related to gene identifier “hph_1391” was selected for updating.  As shown in 
Figure 6, the following gene attributes were selected and modified:  gene description, 
localization, and signal sequence.  Once submitted, all modifications to the data were confirmed 
using “Quick Search”.  DraGnET provides additional functionalities for preliminary analysis of 
draft and complete genome data.  To identify protein products common to all three of the H. 
parasuis strains, “Advanced Search” and BLAST functionalities provided through the DraGnET 
interface were used to perform preliminary cross strain comparisons.  This demonstrates the 
DraGnET application is ideally suited for smaller companies or academic labs that are just 
beginning to use next-generation sequencing for vaccine development.   
 
DISCUSSION 
 While data from genome sequencing projects typically become publicly available through 
sequence repositories, the rate at which large-scale sequence information is being generated and 
subsequent analysis will, in many cases, delay public availability of the data.  In addition, 
sequencing projects where proprietary data are generated are limited as to how the information 
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can be managed and analyzed until it is ready for public reposition.  This limitation emphasizes 
the need for software applications that provide researchers with in-house data management and 
analysis capabilities.  While some of the features of DraGnET are provided with other 
applications, our software provides a user friendly in-house web application that enables 
researchers to manage their own unpublished or proprietary annotated draft genome data at the 
initial stage of development without having prior knowledge of query languages necessary for 
data storage, retrieval and update.   
 Additional features of the application include BLAST capabilities and the automatic 
generation of FASTA files from protein sequence data stored in the database.  A web interface is 
provided for use of stand-alone BLAST alleviating the requirement to perform searches through 
command line and allowing users to search against a single strain or multiple strains as well as 
perform cross strain comparisons once the BLAST database files are created.  DraGnET was 
designed to store and compare different strains from the same species; however the web interface 
design is generic enough to accommodate multiple organisms and their related strains.  
Additionally, the DraGnET software can be further developed to customize the program for 
specific needs.   
 As demonstrated in the case study, DraGnET provides researchers with an application 
that can be used as a first step toward data curation and analysis.  Subsequently, after the data are 
made publicly available, more comprehensive analysis may be performed, for example by any of 
the aforementioned analysis software.  Alternatively, the sequence data can continue to be 
analyzed using in-house programs, including annotation and BLAST comparisons [37, 48]. 
 Currently gene attributes selected for storage and use with DraGnET are fixed.  Further 
development of DraGnET will include the storage of more comprehensive annotation data as 
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well as more advanced functionalities for comparative analysis.                                                                                              
 DraGnET currently contains draft and complete genome data from three strains of H. 
parasuis made available for collaborative research efforts.  Readers are encouraged to visit the 
DraGnET website located at http://www.dragnet.cvm.iastate.edu and examine the 
functionalities of the software. 
 
CONCLUSIONS 
 New genome sequencing methods now allow multiple draft genomes to be generated, 
assembled, and annotated at an unprecedented rate at modest expense.  Following sequencing, 
assembly and annotation, there is an immediate need for the data to be organized, stored, curated 
and formatted for comparative analysis.  The DraGnET software is an ideal in-house tool that 
allows i.) storage and integration of annotated data generated from different annotation platforms 
in a database, ii.) retrieval of gene and strain information based upon basic or advanced search 
parameters, iii.) management of gene and strain information, iv.) generation of FASTA formatted 
files for all strains stored in the database, v.) sequence similarity searches using BLAST, vi.) 
Batch BLAST searches for cross strain comparisons and vii.) retrieval of strain specific genes 
based upon Batch BLAST results.  The application allows for the setup of individual projects 
used on local machines or may be deployed through Internet (or Intranet) access for use by other 
researchers across different locations.  To demonstrate this, we setup a DraGnET project, 
deployed it for Internet access, and identified potential vaccine targets in multiple strains of H. 
parasuis using preliminary cross strain comparisons.   
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Figure 1: Java classes  
Four Java classes are used to define the Gene, Strain, Logininformation and Blastdbupdate 
objects.  The Gene class defines variables for the following annotated gene information: gene 
identification (gid and geneId), gene function (function), the protein sequence (proteinSequence), 
a description of the gene (geneDescription), the name of the gene (geneName), the size of the 
protein (proteinSize), the subcellular localization (localization), if the protein is predicted to be a 
lipoprotein (lipoprotein), if the protein is predicted to have a signal sequence (signalSequence) 
and the set of strains that contain the genes (Set<Strain> strains).  The Strain class defines 
variables for strain information such as a strain identifier (sid and strainId), the strain name 
(strainName), a description of the strain (strainDescription), and the set of genes contained in the 
strain (Set<Gene> genes).  The Logininformation class defines variables for the user login 
identifier (LogininformationId id), the usertype and the time the user logged in (lastlogon).  The 
Blastdbupdate class defines variables for the date the last update was made to the data (dateId 
and updatedDate). 
 
Class Gene {                                                                          
private Integer gid;                                                             
private String geneId;                                                          
private String function;                                                       
private String proteinSequence;                                       
private String geneDescription;                                        
private String geneName;                                                  
private String proteinSize;                                                   
private String localization;                                                  
private String lipoProtein;                                                 
private String signalSequence;                                              
private Set<Strain> strains; } 
Class Strain {                                                              
private Integer sid;                                                    
private String strainId;                                             
private String strainName;                                       
private String strainDescription;                                   
private Set<Gene> genes; }  
                                                                            
Class Logininformation {                                           
private LogininformationId id;                                  
private String usertype;                                            
private Double lastlogon; } 
Class Blastdbupdate {                                                                             
private Integer dateId;                                                                          
private String updatedDate; } 
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Figure 2:  DraGnET software architecture 
The DraGnET web application uses Struts to implement the Model-View-Controller (MVC) architecture.  The view represents the 
presentation of the application and is implemented through Java Server Pages (JSP).  The Controller is responsible for intercepting and 
translating user input into actions to be performed by the Model. The Controller receives the request from the browser, invokes a 
business operation and coordinates the view to be returned to the browser. The Struts Action servlet populates information from the 
JSP to the appropriate Struts Action Form then throws control to the Struts Action.  The Struts Action gets data from the appropriate 
Struts Action Form and sends the information to the Model where certain actions like retrievals and updates will be performed. The 
Model is where communication with the database takes place through Hibernate.  Hibernate is used to map Model Classes (Java 
objects) to tables in the database.  Model Classes are also used to execute BLAST functionalities provided through the application’s 
web interface.  The Model represents enterprise data and the business rules that govern access to and updates of this data.   
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Figure 3: Web interface- DraGnET Home Page 
Listed on the DraGnET home page are links for downloading the DraGnET setup 
package (“DraGnET Application Setup Package”), testing search and BLAST capabilities 
(“Example Files”), generating FASTA formatted files (“Generate FASTA files”) and all 
“Search” functionalities. 
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Figure 4:  Adding a new strain 
The data entry tables displayed on the web pages for inserting a new strain.  In the first 
table (A) the curator enters the strain Id, strain name and strain description of the new 
strain. In the second table (B) the curator is directed to upload a file containing gene 
information for genes contained in the strain.  The strain and gene information is then 
stored in the database.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5:  Data Modification 
The table displayed on the web page for modifying gene and strain data.  As shown in the 
table, modifications that can be made by the curator to gene and strain data include 
adding, deleting and updating gene or strain information.   
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Figure 6:  Updating gene information 
The data entry tables displayed on the web pages for updating gene information.  In the 
top left table (A) the gene Id of the gene whose information needs modification is entered 
and submitted.  The table on the bottom left (B) allows the curator to select gene 
attributes that need to be modified.  Subsequently, as shown in table (C), for each 
attribute selected, the gene information currently stored in the database is displayed on 
the left side of the table as “Old” information and on the right side of the table changes to 
the gene information may be entered under “New”.   
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Figure 7:  Quick Search  
The data entry tables and results table displayed on the web pages for “Quick Search”.  In 
the top left table (A) the user selects a gene or strain search attribute.  In the bottom left 
table (B) the user enters information for the chosen search criteria.  Subsequently, the 
results table (C) displays information for the chosen gene or strain.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8:  Advanced Search 
The data entry tables displayed on the web pages for “Advanced Search”.  Using the table 
on the left (A) users may customize their search for gene information by selecting single 
or multiple search attributes.  The table on the right (B) allows users to enter and select 
values for the chosen search criteria.  Subsequently, a text file containing search results is 
available for download.   
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Figure 9:  BLAST Search 
The data entry table and results displayed on the web pages for “BLAST Search”.  As 
shown in table (A), users have the option to select a single or multiple search database(s).  
In this example we have three BLAST databases available for searching that represent 
strains SH0165, 29755 and 12939.  To refine their search, users have the option to change 
the E-value with the default being .01.  A text box is provided for users to enter a FASTA 
formatted protein query sequence.  The results (B) are displayed to the user and are 
available for download.    
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Figure 10:  Batch BLAST Search 
The data entry table displayed on the web page for “Batch BLAST Search”.  Users select 
a single search database from a drop down menu.  In this example, the BLAST database 
representing strain 29755 was chosen.  To refine their search, users have the option to 
change the E-value with the default being .01.  Users then upload a text file containing 
FASTA formatted protein sequences which will be used as the set of query sequences.  
The results format is the same as “BLAST Search”.       
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CHAPTER 6. General Conclusions 
 Structural determinations of the SRP and receptor have provided details of how 
components of this essential and highly conserved protein localization machinery interact 
in precise detail (1, 2, 6, 7, 9, 10, 14).  In addition, these efforts have led to several 
hypotheses as to how the components function in protein targeting.  It has been the goal 
of the studies described in this dissertation to use the structural information to guide 
experiments designed to better understand how the structure of Ffh directs the function of 
the SRP.  For this, we have taken multiple genetic approaches that, along with 
bioinformatic analyses, have led to new insights into how specific domains of Ffh 
contribute to its activity in vivo.     
 Specifically, we have developed a genetic system that allowed complementation 
tests to be performed using an E. coli strain that conditionally grows at 42
o
C only if it is 
transformed with a plasmid expressing a functional copy of ffh.  This strain has allowed 
us to isolate and test mutants in both the finger loop domain and the M-domain of Ffh to 
understand the importance of specific amino acids in each region of the protein.  In 
addition, we have overcome a limitation with performing complementation test using 
multiple copy number plasmids by utilizing a system to express mutant alleles in single 
copy so that their expression will be more physiologically relevant (13).                                                                                                         
 Due to the flexibility and hydrophobic nature of the finger loop domain of Ffh, 
structural information is lacking and has therefore been difficult to study.   However, by 
screening a random sequence library (4, 11, 12, 15), we were able to select sequences that 
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could replace the wild type finger loop domain and provide a functional SRP.  
Bioinformatic analyses of several of these mutants revealed two important features, 
including the necessity of maintaining a highly hydrophobic N-terminus along with a 
decrease in hydrophobicity toward the C-terminal end.  Comparison of the finger loop 
domain from multiple species also revealed that while there is considerable variation in 
the residue composition of the finger loop toward the C-terminus, the physicochemical 
properties of the amino acids are similar.  Our results support the proposal that the finger 
loop domain contributes to the hydrophobic interactions in signal sequence binding and 
provides additional flexibility to the signal sequence binding domain of Ffh required for 
accommodating a variety of signal sequences (3, 5, 8).  The observed periodic 
distribution of hydrophobic amino acids and the gradient of hydrophobicity throughout 
the finger loop domain are in support of the contribution of flexibility this domain 
provides to Ffh signal sequence binding.                                                                                                                                   
 To further characterize the M-domain of Ffh, we turned our focus to the 
importance of methionine residues.  Although the importance of “methionine bristles” 
had been suggested for Ffh function, there have been no direct tests of this hypothesis.  It 
had been previously observed that methionine residues found in the M-domain of Ffh 
from E. coli were substituted in T. aquaticus with less flexible hydrophobic amino acids 
such as leucine, isoleucine and phenylalanine (9).  By performing a more extensive 
phylogenetic sequence analysis of Ffh from bacteria and archaea representing varying 
optimal growth temperatures (OGT), including hyperthermophiles (≥75oC), thermophiles 
(between 40
o
C and 75
o
C), psychrophiles (between 10
o
C and 15
o
C) and mesophiles 
(between 25
o
C and 40
o
C) we observed that indeed methionine residues are found at a 
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higher percentage in psychrophiles and mesophiles than hyperthermophiles and 
thermophiles.   
As a direct test of the importance of methionines in Ffh function, we also 
constructed a series of mutants by substituting all of the methionines within the αM4 
helix at the extreme C-terminus of Ffh with several other amino acids.  For this, we 
selected additional hydrophobic residues, including alanine, cysteine, leucine, isoleucine, 
phenylalanine, valine, tyrosine and tryptophan, as well the charged amino acid glutamate.  
By expressing mutant ffh alleles in single and multiple copy, we were able to clearly 
determine that residues valine, phenylalanine, tyrosine, tryptophan, and isoleucine could 
function to replace methionine residues found in αM4 helix and the extreme C-terminal 
region of the M-domain.  Surprisingly, we observed that the ffhα4MV mutant grew 
near wild type levels, while substitutions of leucine and isoleucine, both having side 
chains more similar to methionine, were extremely poor replacements.  Mutant 
ffhα4MV was able to support cell viability at several growth temperatures (30oC, 37oC 
and 42
o
C) when present in single and multiple copy; however, ffhα4MI, when present 
in single copy, only supported growth of SLD106 at 42
o
C.   Additionally, elevated 
expression of the product of ffhα4ML was required to support growth of SLD106 at 
42
o
C, albeit the colonies were unable to form single colonies upon restreaking.                                                           
 From these unexpected results, we tested the ability of valine to replace all of the 
methionines in the complete M-domain.  While this mutant failed to support growth, 
addition of 3 highly conserved methionines (positions 344, 383 and 426 corresponding to 
the E. coli Ffh protein) restored SRP function.  Further studies will be required to 
determine if any of these methionine residues are necessary for Ffh function.                                                              
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 In conclusion, our results provide further insights into characteristics of the signal 
sequence binding domain of Ffh and call into question the necessity of methionine 
residues found in the M-domain of Ffh from E. coli.  Future research directions include 
additional mutational analysis of three highly conserved methionine residues found in the 
M-domain in order to determine the importance of these residues in signal sequence 
recognition.  In addition, biochemical analysis of the finger loop mutants will be 
informative in order to identify how changes in this unstructured domain affect SRP 
function and to further elucidate its role in Ffh function.  
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